Activation	O
of	O
a	O
novel	B-DNA
gene	I-DNA
in	O
3q21	B-DNA
and	O
identification	O
of	O
intergenic	O
fusion	O
transcripts	O
with	O
ecotropic	B-DNA
viral	I-DNA
insertion	I-DNA
site	I-DNA
I	I-DNA
in	O
leukemia	O
.	O

We	O
have	O
identified	O
a	O
novel	B-DNA
gene	I-DNA
,	O
GR6	B-DNA
,	O
located	O
within	O
the	O
leukemia	O
breakpoint	O
region	O
of	O
3q21	B-DNA
,	O
that	O
is	O
normally	O
expressed	O
in	O
early	O
fetal	O
development	O
but	O
not	O
in	O
adult	O
peripheral	O
blood	O
.	O

GR6	B-DNA
is	O
activated	O
in	O
the	O
UCSD-AML1	B-cell_line
cell	I-cell_line
line	I-cell_line
and	O
in	O
a	O
leukemic	B-cell_line
sample	I-cell_line
,	O
both	O
of	O
which	O
carry	O
a	O
t	B-DNA
(	I-DNA
3	I-DNA
;	I-DNA
3	I-DNA
)	I-DNA
(	I-DNA
q21	I-DNA
;	I-DNA
q26	I-DNA
)	I-DNA
.	O

In	O
UCSD-AML1	B-cell_line
,	O
we	O
have	O
also	O
identified	O
fusion	B-RNA
transcripts	I-RNA
between	O
the	O
ecotropic	B-DNA
viral	I-DNA
insertion	I-DNA
site	I-DNA
I	I-DNA
(	I-DNA
EVI1	I-DNA
)	I-DNA
gene	I-DNA
in	O
3q26	B-DNA
and	O
GR6	B-DNA
and	O
between	O
EVI1	B-DNA
and	O
Ribophorin	B-DNA
I	I-DNA
that	O
maps	O
30	O
kb	O
telomeric	O
to	O
GR6	B-DNA
in	O
3q21	B-DNA
.	O

All	O
fusions	O
splice	O
the	O
5	B-DNA
'	I-DNA
ends	I-DNA
of	O
the	O
3q21	B-DNA
genes	I-DNA
into	O
exon	B-DNA
2	I-DNA
of	O
the	O
EVI1	B-DNA
gene	O
,	O
an	O
event	O
that	O
is	O
similar	O
to	O
the	O
normal	O
intergenic	O
splicing	O
of	O
MDS1-EVI1	B-DNA
and	O
to	O
those	O
previously	O
documented	O
in	O
leukemias	O
with	O
t	B-DNA
(	I-DNA
3	I-DNA
;	I-DNA
21	I-DNA
)	I-DNA
and	O
t	B-DNA
(	I-DNA
3	I-DNA
;	I-DNA
12	I-DNA
)	I-DNA
,	O
in	O
which	O
acute	O
myelogenous	B-DNA
leukemia	I-DNA
1-EVI1	I-DNA
fusions	I-DNA
and	O
ETV6-EVI1	B-DNA
fusions	I-DNA
,	O
respectively	O
,	O
occur	O
.	O

The	O
Ribophorin	B-DNA
I-EVI1	I-DNA
fusion	I-DNA
in	O
particular	O
may	O
be	O
a	O
common	O
occurrence	O
in	O
t	B-DNA
(	I-DNA
3	I-DNA
;	I-DNA
3	I-DNA
)	I-DNA
.	O

[	NULL
CANCER	NULL
RESEARCH	NULL
57	NULL
,	NULL
3914-3919	NULL
,	NULL
September	NULL
15	NULL
,	NULL
1997	NULL
]	NULL
Advances	NULL
in	NULL
Brief	NULL
Activation	NULL
of	NULL
a	NULL
Novel	NULL
Gene	NULL
in	NULL
3q21	NULL
and	NULL
Identification	NULL
of	NULL
Intergenic	NULL
Fusion	NULL
Transcripts	NULL
with	NULL
Ecotropic	NULL
Viral	NULL
Insertion	NULL
Site	NULL
I	NULL
in	NULL
Leukemia	NULL
'	NULL
Yuri	NULL
Pekarsky	NULL
,	NULL
Alla	NULL
Rynditch	NULL
,	NULL
Rotraud	NULL
Wieser	NULL
,	NULL
Christa	NULL
Fonatsch	NULL
,	NULL
and	NULL
Katheleen	NULL
Gardiner	NULL
Eleanor	NULL
Roosevelt	NULL
Institute	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80206	NULL
[	NULL
Y.	NULL
P.	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
K.	NULL
G.	NULL
]	NULL
;	NULL
Institute	NULL
of	NULL
Molecular	NULL
Biology	NULL
and	NULL
Genetics	NULL
,	NULL
National	NULL
Academy	NULL
of	NULL
Sciences	NULL
of	NULL
Ukraine	NULL
,	NULL
Kiev	NULL
,	NULL
143	NULL
.	NULL

25243	NULL
Ukraine	NULL
[	NULL
A.	NULL
R.	NULL
}	NULL
;	NULL
and	NULL
Institut	NULL
fiir	NULL
Medizinische	NULL
Biologie	NULL
der	NULL
Universitit	NULL
Wien	NULL
,	NULL
1090	NULL
Vienna	NULL
,	NULL
Austria	NULL
[	NULL
R.	NULL
W.	NULL
,	NULL
C.	NULL
F.	NULL
]	NULL
Abstract	NULL
We	NULL
have	NULL
identified	NULL
a	NULL
novel	NULL
gene	NULL
,	NULL
GR6	NULL
,	NULL
located	NULL
within	NULL
the	NULL
leukemia	NULL
breakpoint	NULL
region	NULL
of	NULL
3q21	NULL
,	NULL
that	NULL
is	NULL
normally	NULL
expressed	NULL
in	NULL
early	NULL
fetal	NULL
development	NULL
but	NULL
not	NULL
in	NULL
adult	NULL
peripheral	NULL
blood	NULL
.	NULL

GR6	NULL
is	NULL
activated	NULL
in	NULL
the	NULL
UCSD-AML1	NULL
cell	NULL
line	NULL
and	NULL
in	NULL
a	NULL
leukemic	NULL
sample	NULL
,	NULL
both	NULL
of	NULL
which	NULL
carry	NULL
a	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
(	NULL
q21	NULL
;	NULL
q26	NULL
)	NULL
.	NULL

In	NULL
UCSD-AML1I	NULL
,	NULL
we	NULL
have	NULL
also	NULL
identified	NULL
fusion	NULL
transcripts	NULL
between	NULL
the	NULL
ecotropic	NULL
viral	NULL
insertion	NULL
site	NULL
I	NULL
(	NULL
EVZZ	NULL
)	NULL
gene	NULL
in	NULL
3q26	NULL
and	NULL
GR6	NULL
and	NULL
between	NULL
EVI1	NULL
and	NULL
Ribophorin	NULL
I	NULL
that	NULL
maps	NULL
30	NULL
kb	NULL
telomeric	NULL
to	NULL
GR6	NULL
in	NULL
3q21	NULL
.	NULL

All	NULL
fusions	NULL
splice	NULL
the	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
3q21	NULL
genes	NULL
into	NULL
exon	NULL
2	NULL
of	NULL
the	NULL
EVI1	NULL
gene	NULL
,	NULL
an	NULL
event	NULL
that	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
normal	NULL
intergenic	NULL
splicing	NULL
of	NULL
MDS1-EVI1	NULL
and	NULL
to	NULL
those	NULL
previously	NULL
documented	NULL
in	NULL
leukemias	NULL
with	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
and	NULL
t	NULL
(	NULL
3	NULL
;	NULL
12	NULL
)	NULL
,	NULL
in	NULL
which	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
1-EVI1	NULL
fusions	NULL
and	NULL
ETV6-EVI1	NULL
fusions	NULL
,	NULL
respectively	NULL
,	NULL
occur	NULL
.	NULL

The	NULL
Ribophorin	NULL
I-EVIl	NULL
fusion	NULL
in	NULL
particular	NULL
may	NULL
be	NULL
a	NULL
common	NULL
occurrence	NULL
in	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
.	NULL

Introduction	NULL
The	NULL
involvement	NULL
of	NULL
3q21	NULL
and	NULL
3q26	NULL
in	NULL
rearrangements	NULL
in	NULL
leukemia	NULL
is	NULL
well	NULL
established	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Translocations	NULL
,	NULL
inversions	NULL
,	NULL
and	NULL
deletions	NULL
in	NULL
and	NULL
between	NULL
3q21	NULL
and	NULL
3q26	NULL
are	NULL
seen	NULL
in	NULL
4-6	NULL
%	NULL
of	NULL
AML	NULL
s*	NULL
and	NULL
also	NULL
in	NULL
some	NULL
chronic	NULL
myelogenous	NULL
leukemias	NULL
,	NULL
therapy-related	NULL
leukemias	NULL
,	NULL
and	NULL
MDSs	NULL
.	NULL

In	NULL
many	NULL
of	NULL
these	NULL
cases	NULL
,	NULL
the	NULL
zinc	NULL
finger	NULL
transcription	NULL
factor	NULL
,	NULL
the	NULL
EVIL	NULL
gene	NULL
,	NULL
which	NULL
maps	NULL
to	NULL
3q26	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
aberrantly	NULL
activated	NULL
(	NULL
2-5	NULL
)	NULL
.	NULL

Breakpoints	NULL
within	NULL
3q26	NULL
that	NULL
can	NULL
effect	NULL
this	NULL
activation	NULL
have	NULL
been	NULL
mapped	NULL
over	NULL
large	NULL
regions	NULL
,	NULL
up	NULL
to	NULL
several	NULL
hundred	NULL
kb	NULL
either	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
to	NULL
EVIL	NULL
.	NULL

Regulation	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
EVI	NULL
!	NULL

gene	NULL
appears	NULL
complicated	NULL
.	NULL

In	NULL
normal	NULL
tissues	NULL
,	NULL
EVZZ	NULL
and	NULL
a	NULL
gene	NULL
of	NULL
unknown	NULL
function	NULL
,	NULL
MDS1	NULL
,	NULL
located	NULL
170-300	NULL
kb	NULL
upstream	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
exist	NULL
both	NULL
as	NULL
separate	NULL
transcripts	NULL
and	NULL
as	NULL
spliced	NULL
products	NULL
,	NULL
where	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
MDSI1	NULL
is	NULL
spliced	NULL
into	NULL
exon	NULL
2	NULL
of	NULL
EVI	NULL
!	NULL

(	NULL
6	NULL
)	NULL
.	NULL

Because	NULL
exon	NULL
2	NULL
of	NULL
EVI	NULL
!	NULL

is	NULL
otherwise	NULL
not	NULL
translated	NULL
,	NULL
this	NULL
intergenic	NULL
splicing	NULL
produces	NULL
a	NULL
radically	NULL
different	NULL
5	NULL
'	NULL
protein	NULL
sequence	NULL
.	NULL

The	NULL
complexities	NULL
of	NULL
the	NULL
MDSI/EVII	NULL
gene	NULL
organization	NULL
and	NULL
regulation	NULL
in	NULL
3q26	NULL
have	NULL
not	NULL
been	NULL
reported	NULL
for	NULL
other	NULL
human	NULL
genes	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
3q26	NULL
,	NULL
the	NULL
precise	NULL
role	NULL
of	NULL
sequences	NULL
in	NULL
3q21	NULL
is	NULL
less	NULL
well	NULL
described	NULL
.	NULL

Breakpoints	NULL
here	NULL
are	NULL
clustered	NULL
;	NULL
the	NULL
10	NULL
that	NULL
have	NULL
been	NULL
mapped	NULL
are	NULL
located	NULL
within	NULL
a	NULL
segment	NULL
no	NULL
more	NULL
than	NULL
30	NULL
kb	NULL
in	NULL
size	NULL
(	NULL
7-9	NULL
)	NULL
.	NULL

The	NULL
RBPH1	NULL
gene	NULL
maps	NULL
20	NULL
kb	NULL
telomeric	NULL
to	NULL
this	NULL
region	NULL
,	NULL
an	NULL
observation	NULL
that	NULL
has	NULL
led	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
an	NULL
associated	NULL
enhancer	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
EVI1	NULL
(	NULL
7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
several	NULL
additional	NULL
transcriptional	NULL
units	NULL
have	NULL
been	NULL
described	NULL
within	NULL
an	NULL
80-kb	NULL
segment	NULL
,	NULL
Received	NULL
6/10/97	NULL
;	NULL
accepted	NULL
7/28/97	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
The	NULL
Dale	NULL
Tooley	NULL
Cancer	NULL
Research	NULL
Support	NULL
Fund	NULL
and	NULL
American	NULL
Cancer	NULL
Society	NULL
Grant	NULL
VM-122	NULL
(	NULL
to	NULL
K.	NULL
G.	NULL
)	NULL
;	NULL
National	NULL
Cancer	NULL
Institute	NULL
Grant	NULL
CA46934	NULL
to	NULL
the	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Sciences	NULL
Center	NULL
Cancer	NULL
Center	NULL
(	NULL
to	NULL
K.	NULL
G.	NULL
)	NULL
;	NULL
and	NULL
FWF	NULL
Grant	NULL
P11803-GEN	NULL
(	NULL
to	NULL
C.	NULL
F.	NULL
)	NULL
.	NULL

*	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
,	NULL
at	NULL
Eleanor	NULL
Roosevelt	NULL
Institute	NULL
,	NULL
1899	NULL
Gaylord	NULL
Street	NULL
,	NULL
Denver	NULL
,	NULL
CO	NULL
80206	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
AML	NULL
,	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
;	NULL
MDS	NULL
,	NULL
myelodysplastic	NULL
syndrome	NULL
;	NULL
EVI1	NULL
,	NULL
ecotropic	NULL
viral	NULL
insertion	NULL
site	NULL
I	NULL
;	NULL
RBPH1	NULL
,	NULL
Ribophorin	NULL
I	NULL
;	NULL
RACE	NULL
,	NULL
rapid	NULL
amplification	NULL
of	NULL
cDNA	NULL
ends	NULL
;	NULL
RT-PCR	NULL
,	NULL
reverse	NULL
transcription	NULL
PCR	NULL
;	NULL
IT	NULL
,	NULL
intergenic	NULL
transcript	NULL
.	NULL

immediately	NULL
proximal	NULL
to	NULL
RBPH	NULL
!	NULL

T	NULL
and	NULL
spanning	NULL
the	NULL
breakpoint	NULL
region	NULL
(	NULL
9	NULL
)	NULL
.	NULL

These	NULL
putative	NULL
genes	NULL
are	NULL
novel	NULL
,	NULL
of	NULL
unknown	NULL
function	NULL
,	NULL
and	NULL
generally	NULL
expressed	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
normal	NULL
tissues	NULL
.	NULL

The	NULL
density	NULL
of	NULL
genes	NULL
and	NULL
the	NULL
dispersion	NULL
of	NULL
breakpoints	NULL
suggests	NULL
that	NULL
leukemia	NULL
rearrangements	NULL
may	NULL
make	NULL
a	NULL
number	NULL
of	NULL
different	NULL
transcriptional	NULL
alterations	NULL
possible	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
describe	NULL
several	NULL
of	NULL
these	NULL
alterations	NULL
in	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
(	NULL
q21	NULL
;	NULL
q26	NULL
)	NULL
,	NULL
seen	NULL
in	NULL
the	NULL
leukemia-derived	NULL
cell	NULL
line	NULL
,	NULL
UCSD-AML1	NULL
(	NULL
10	NULL
)	NULL
,	NULL
and	NULL
in	NULL
a	NULL
leukemia	NULL
sample	NULL
.	NULL

A	NULL
novel	NULL
gene	NULL
,	NULL
GR6	NULL
,	NULL
within	NULL
3q21	NULL
,	NULL
has	NULL
been	NULL
characterized	NULL
and	NULL
shown	NULL
to	NULL
be	NULL
normally	NULL
expressed	NULL
in	NULL
early	NULL
fetus	NULL
but	NULL
not	NULL
in	NULL
adult	NULL
lymphocytes	NULL
or	NULL
lymphoblastoid	NULL
cells	NULL
.	NULL

GR6	NULL
is	NULL
,	NULL
however	NULL
,	NULL
activated	NULL
in	NULL
the	NULL
leukemia-derived	NULL
cell	NULL
line	NULL
,	NULL
UCSD-AML1	NULL
,	NULL
and	NULL
in	NULL
the	NULL
one	NULL
additional	NULL
leukemic	NULL
sample	NULL
tested	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
GR6	NULL
and	NULL
RBPH1	NULL
separately	NULL
participate	NULL
in	NULL
intergenic	NULL
splicing	NULL
events	NULL
with	NULL
the	NULL
EVZZ	NULL
gene	NULL
in	NULL
the	NULL
UCSD-AML1	NULL
cell	NULL
line	NULL
.	NULL

From	NULL
information	NULL
on	NULL
the	NULL
locations	NULL
of	NULL
other	NULL
leukemic	NULL
breakpoints	NULL
in	NULL
3q21	NULL
,	NULL
the	NULL
occurrence	NULL
of	NULL
at	NULL
least	NULL
the	NULL
RBPH1-EVI1-spliced	NULL
product	NULL
may	NULL
be	NULL
a	NULL
common	NULL
event	NULL
in	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
(	NULL
q21	NULL
;	NULL
q26	NULL
)	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Lines	NULL
.	NULL

The	NULL
leukemia-derived	NULL
UCSD-AML1	NULL
cell	NULL
line	NULL
,	NULL
carrying	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
(	NULL
q21	NULL
;	NULL
q26	NULL
)	NULL
,	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
CGM-1	NULL
(	NULL
received	NULL
from	NULL
M.	NULL
V.	NULL
Olsen	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
normal	NULL
control	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
15	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

For	NULL
the	NULL
UCSD-AML1	NULL
cell	NULL
line	NULL
,	NULL
100	NULL
units/ml	NULL
granulocyte	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
was	NULL
added	NULL
to	NULL
the	NULL
medium	NULL
.	NULL

Sequence	NULL
Analysis	NULL
,	NULL
Sequencing	NULL
within	NULL
the	NULL
3q21	NULL
breakpoint	NULL
region	NULL
has	NULL
been	NULL
described	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Twenty-five	NULL
kb	NULL
of	NULL
sequence	NULL
,	NULL
spanning	NULL
12	NULL
kb	NULL
telomeric	NULL
to	NULL
the	NULL
UCSD-AML1	NULL
breakpoint	NULL
to	NULL
13	NULL
kb	NULL
centromeric	NULL
,	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
GenBank	NULL
database	NULL
(	NULL
accession	NULL
no	NULL
.	NULL

AFOO8191	NULL
)	NULL
.	NULL

In	NULL
this	NULL
sequence	NULL
,	NULL
Grail	NULL
analysis	NULL
(	NULL
11	NULL
)	NULL
predicted	NULL
exons	NULL
at	NULL
nucleotides	NULL
7,716-7,797	NULL
,	NULL
8,573-8,744	NULL
,	NULL
and	NULL
10,246-10,368	NULL
,	NULL
and	NULL
the	NULL
GR6	NULL
gene	NULL
was	NULL
determined	NULL
to	NULL
extend	NULL
from	NULL
nucleotide	NULL
6,404	NULL
to	NULL
10,488	NULL
.	NULL

For	NULL
brevity	NULL
,	NULL
Fig	NULL
.	NULL

1c	NULL
gives	NULL
the	NULL
nucleotide/amino	NULL
acid	NULL
sequence	NULL
of	NULL
only	NULL
the	NULL
GR6	NULL
exons	NULL
.	NULL

Table	NULL
1	NULL
lists	NULL
the	NULL
names	NULL
,	NULL
sequences	NULL
,	NULL
and	NULL
nucleotide	NULL
numbers	NULL
(	NULL
from	NULL
the	NULL
GR6	NULL
exon	NULL
sequences	NULL
in	NULL
Fig	NULL
.	NULL

1c	NULL
)	NULL
of	NULL
the	NULL
primers	NULL
used	NULL
in	NULL
RACE	NULL
and	NULL
RT-PCR	NULL
experiments	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
structure	NULL
of	NULL
GR6	NULL
.	NULL

RNA	NULL
Isolation	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
2	NULL
X	NULL
10°-10	NULL
x	NULL
10°	NULL
cells	NULL
,	NULL
from	NULL
7-8-week	NULL
whole	NULL
fetuses	NULL
and	NULL
from	NULL
adult	NULL
lymphocytes	NULL
by	NULL
standard	NULL
guanidine	NULL
thiocyanate	NULL
procedures	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
+	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
0.2-1.0	NULL
mg	NULL
of	NULL
total	NULL
RNA	NULL
using	NULL
Mini-Oligo	NULL
(	NULL
dT	NULL
)	NULL
Cellulose	NULL
Spin	NULL
Columns	NULL
(	NULL
5	NULL
Prime	NULL
-	NULL
3	NULL
Prime	NULL
)	NULL
.	NULL

RNA	NULL
quality	NULL
was	NULL
checked	NULL
on	NULL
0.8	NULL
%	NULL
agarose	NULL
denaturing	NULL
gels	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
+	NULL
RNA	NULL
for	NULL
sample	NULL
no	NULL
.	NULL

32	NULL
was	NULL
prepared	NULL
from	NULL
a	NULL
leukemic	NULL
sample	NULL
carrying	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
(	NULL
q21	NULL
;	NULL
q26	NULL
)	NULL
.	NULL
``	NULL

Northern	NULL
blots	NULL
containing	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
+	NULL
RNA	NULL
were	NULL
prepared	NULL
from	NULL
whole	NULL
fetus	NULL
,	NULL
adult	NULL
lymphocytes	NULL
,	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

Additional	NULL
Northern	NULL
blots	NULL
containing	NULL
RNA	NULL
from	NULL
adult	NULL
tissues	NULL
,	NULL
18-24-week	NULL
fetal	NULL
tissues	NULL
,	NULL
and	NULL
cancer	NULL
cell	NULL
lines	NULL
were	NULL
purchased	NULL
from	NULL
Clontech	NULL
.	NULL

RT-PCR	NULL
.	NULL

Five	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
were	NULL
treated	NULL
with	NULL
DNase	NULL
I	NULL
(	NULL
amplification	NULL
grade	NULL
;	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
directions	NULL
.	NULL

DNase	NULL
I-treated	NULL
RNA	NULL
was	NULL
used	NULL
in	NULL
reverse	NULL
transcription	NULL
reactions	NULL
as	NULL
follows	NULL
:	NULL
10	NULL
nM	NULL
each	NULL
dNTP	NULL
,	NULL
100	NULL
pmo	NULL
!	NULL

of	NULL
random	NULL
hexamers	NULL
,	NULL
RNA	NULL
,	NULL
and	NULL
200	NULL
units	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
in	NULL
total	NULL
*S.	NULL
Schnittger	NULL
,	NULL
C.	NULL
Dannenberg	NULL
,	NULL
A.	NULL
Jassemien	NULL
,	NULL
K.	NULL
Gardiner	NULL
,	NULL
Y.	NULL
Pekarsky	NULL
,	NULL
and	NULL
C.	NULL
Fonatsch	NULL
,	NULL
Molecular	NULL
analysis	NULL
of	NULL
breakpoints	NULL
in	NULL
3q21	NULL
and	NULL
3q26	NULL
in	NULL
patients	NULL
with	NULL
leukemia	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

3914	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1997	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
GR6	NULL
gene	NULL
.	NULL

a	NULL
,	NULL
location	NULL
and	NULL
orientation	NULL
of	NULL
the	NULL
GR6	NULL
gene	NULL
in	NULL
3q21	NULL
,	NULL
relative	NULL
to	NULL
the	NULL
breakpoint	NULL
in	NULL
the	NULL
leukemia-derived	NULL
cell	NULL
line	NULL
UCSD-AML1	NULL
(	NULL
10	NULL
)	NULL
and	NULL
to	NULL
the	NULL
previously	NULL
described	NULL
novel	NULL
genes	NULL
GR2	NULL
,	NULL
P2	NULL
,	NULL
and	NULL
/B1	NULL
(	NULL
9	NULL
)	NULL
and	NULL
the	NULL
RBPH1	NULL
gene	NULL
,	NULL
located	NULL
telomeric	NULL
to	NULL
the	NULL
NotI	NULL
site	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
GR6	NULL
,	NULL
P2	NULL
,	NULL
and	NULL
RBPH1	NULL
are	NULL
all	NULL
transcribed	NULL
in	NULL
the	NULL
telomere-to-centromere	NULL
direc-tion	NULL
.	NULL

b	NULL
,	NULL
enlargement	NULL
of	NULL
the	NULL
GR6	NULL
gene	NULL
structure	NULL
,	NULL
showing	NULL
exons	NULL
1-4	NULL
and	NULL
the	NULL
observed	NULL
alternative	NULL
splicing	NULL
products	NULL
.	NULL

c	NULL
,	NULL
sequence	NULL
of	NULL
the	NULL
GR6	NULL
exons	NULL
.	NULL

Boundaries	NULL
of	NULL
the	NULL
exons	NULL
are	NULL
indicated	NULL
above	NULL
the	NULL
nucleotide	NULL
sequence	NULL
.	NULL

The	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
ORF	NULL
in	NULL
exon	NULL
4	NULL
is	NULL
shown	NULL
below	NULL
the	NULL
nucleotide	NULL
sequence	NULL
.	NULL

*	NULL
,	NULL
the	NULL
three	NULL
amino	NULL
acids	NULL
spliced	NULL
into	NULL
EVI	NULL
!	NULL

in	NULL
IT1	NULL
;	NULL
**	NULL
,	NULL
the	NULL
underlined	NULL
amino	NULL
acid	NULL
sequence	NULL
is	NULL
spliced	NULL
into	NULL
EVI1	NULL
in	NULL
IT2	NULL
and	NULL
IT3	NULL
;	NULL
***	NULL
,	NULL
stop	NULL
codon	NULL
.	NULL

The	NULL
complete	NULL
nucleotide	NULL
sequence	NULL
,	NULL
including	NULL
introns	NULL
,	NULL
can	NULL
be	NULL
found	NULL
in	NULL
GenBank	NULL
database	NULL
(	NULL
accession	NULL
no	NULL
.	NULL

AFOO8192	NULL
)	NULL
.	NULL

d	NULL
,	NULL
RT-PCR	NULL
showing	NULL
activation	NULL
of	NULL
GR6	NULL
in	NULL
leukemia	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
normal	NULL
lymphocytes	NULL
;	NULL
Lane	NULL
2	NULL
,	NULL
UCSD-AML1	NULL
cell	NULL
line	NULL
[	NULL
with	NULL
1	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
]	NULL
;	NULL
Lane	NULL
3	NULL
,	NULL
CGM-1	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
;	NULL
Lane	NULL
4	NULL
,	NULL
7-8-week	NULL
fe-tus	NULL
;	NULL
Lane	NULL
5	NULL
,	NULL
leukemic	NULL
sample	NULL
32	NULL
[	NULL
with	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
;	NULL
Ref	NULL
.	NULL

19	NULL
]	NULL
.	NULL

GR6	NULL
included	NULL
30	NULL
cycles	NULL
of	NULL
amplifica-tion	NULL
;	NULL
actin	NULL
with	NULL
17	NULL
cycles	NULL
of	NULL
amplification	NULL
is	NULL
shown	NULL
for	NULL
comparison	NULL
.	NULL

+	NULL
,	NULL
reactions	NULL
with	NULL
reverse	NULL
transcriptase	NULL
;	NULL
-	NULL
,	NULL
without	NULL
reverse	NULL
transcriptase	NULL
.	NULL

FUSION	NULL
TRANSCRIPTS	NULL
WITH	NULL
EVII	NULL
IN	NULL
LEUKEMIA	NULL
10	NULL
kb	NULL
*~	NULL
UCSD-AML1	NULL
L	NULL
--	NULL
TEL	NULL
breakpoint	NULL
3021	NULL
BCR	NULL
4	NULL
C	NULL
Not	NULL
I	NULL
«	NULL
all-	NULL
al-	NULL
tlf	NULL
-__-a	NULL
ars	NULL
GR2	NULL
p2	NULL
1B1	NULL
RBPH	NULL
I	NULL
C	NULL
AGCAATTGGGAACAGAAAGTGCTTCCTGTCCCGGCCTGAGACAATGGACAATAAACCCAGCCTGGTGGGCCCCGGCCCCTGACCCCAAGG	NULL
CTTCAGGAAGAGGCTCCCACACGCACACACCTGCGGTGTGCGAAGCTCGCATTGTTCTGGGCTCATGGCCGAGTAGGGCCCCTTGCTCTC	NULL
AGGAGCCTCCAGCTCTTTCTGGACCTGAGCCCTGGGAGCCTTCACTCTGCCCAGATGTGCTTCCTGTGGAAGGAGACCCCCAGATGACAC	NULL
b_I_9	NULL
1\/2	NULL
AGATGGAGTCTTGCTCTGTCACCCAGGCTGGAATGCAGTGGCATGATCTTGGCTCACTGAAACCTCTGCCTCCCGGTTCAAGCAATICTC	NULL
/	NULL
CTGCCTCAGCCTCCTGAGTAGCTGGGATTACAGAAAATCTGAGCAGTGGGTGAGGCCGAGGGACTGCCCAGAGCCCCAGAGCACGGCAGT	NULL
a	NULL
GGGCAAGCAGTCGTCCCTGTCCTGGGCATCCCTGTGGCCATGGAGCTCCTGGGTGAGCAGCTGCTCTGAGACAAGTCTGGTGAAGAATAC	NULL
AGCAGGACTCCTGAACATTCTTCCTTAAATGCTTATCTGTGGAAACCAGAACTGCCCTTGGCGCGTGGCTCGTGGACGTGCTGGGTGGCT	NULL
GGGTGGGGCGGGTGCACGGGTMAGCCTCAGCTCTGTTTCTTTCTCTGGGTAGTGTCCCCACTGCCGGGCTTCTCCCGCTCTCAGCTC\	NULL
‘	NULL
§C	NULL
3a\/4	NULL
TGGGGAGGTCCCCTGTGAAGGGCCTGTCTTTCCTGTCCCCTCCCTCGGATCATTAATGAACCACTCTCTCTCTCTTTTTCCTTTTCAGTG	NULL
ATTGGGCTGTCGGAATCAAAGAGGCCCTCCGGTGACTCAGGCGTTTCCCATTGCCCTATTCTAGCATCCTCTACTCTTAGCACTGAGAGT	NULL
TTTTCACGTCCTATTTGGAACTGATAGGAAACCCTTTCATTIGTTTCGCTACATGGATATTAGCACTGATGAAGGAAGCGCTCCATCAGAT	NULL
Mo	NULL
K	NULL
B	NULL
A	NULL
L	NULL
BH	NULL
Q	NULL
I	NULL
AGTGGTCCGCTGCAGTGAGCTGGTTTCCAGCACGAGCCTGCCTAGACTCAGCGTCTCCCGCCTCCAGGGACCCCCAGACTCTCAGCCCCT	NULL
v	NULL
v	NULL
R	NULL
C	NULL
S	NULL
B	NULL
L	NULL
V	NULL
Ss	NULL
S	NULL
T	NULL
$	NULL
s	NULL
L	NULL
P	NULL
R	NULL
L	NULL
8	NULL
V	NULL
8	NULL
R	NULL
L	NULL
Q	NULL
G	NULL
P	NULL
P	NULL
D	NULL
8	NULL
Q	NULL
P	NULL
L	NULL
AGGCACCC	NULL
'	NULL
I	NULL
‘	NULL
GGGCCAGGGTGGTTGGMGC	NULL
’	NULL
I	NULL
‘	NULL
1	NULL
‘	NULL
CTAGGCATTGTGGGGTCTCTGGCACCAGAGACACTCGGGGGTCTGGGGACCGAGTTTGG	NULL
6	NULL
T	NULL
L	NULL
Q	NULL
6	NULL
6	NULL
KOL	NULL
E	NULL
L	NULL
Er	NULL
GCCC	NULL
'	NULL
I	NULL
’	NULL
GTACCCACCCACTACCA	NULL
‘	NULL
I	NULL
‘	NULL
TTGACATGGTGAGAGAGAGAGAGAGAGATGACGAGCTCAGGCAGGGATGGCmTCCAGTGCCCACA	NULL
P	NULL
T	NULL
HOP	NULL
P	NULL
R	NULL
E	NULL
L	NULL
R	NULL
Q	NULL
G	NULL
W	NULL
L	NULL
L	NULL
Q	NULL
C	NULL
Pr	NULL
Q	NULL
M_A	NULL
§	NULL
P	NULL
Y	NULL
P	NULL
2	NULL
ATGTGCCAGGACTCTGCTGTGCCACTGTGGGCCTTTCCTCACCCCTCCCTCCCAGACATCAAGCTCCGGTTTCCAGCTGTGTTCCTTGAA	NULL
C	NULL
A	NULL
Ro	NULL
f	NULL
L	NULL
L	NULL
C	NULL
H	NULL
C	NULL
G	NULL
POF	NULL
L	NULL
T	NULL
P	NULL
P	NULL
S	NULL
T	NULL
§	NULL
§	NULL
s	NULL
6	NULL
P	NULL
Q	NULL
L	NULL
8	NULL
L	NULL
K	NULL
M_G	NULL
@	NULL
D_	NULL
S	NULL
A	NULL
Y	NULL
P	NULL
_L	NULL
_	NULL
W	NULL
A	NULL
_P__P_	NULL
H	NULL
P	NULL
§	NULL
L	NULL
P	NULL
D	NULL
_I	NULL
K	NULL
L	NULL
R	NULL
F	NULL
_	NULL
P_	NULL
A	NULL
V	NULL
PL	NULL
E	NULL
ccccrccsecrctcrcercmasccncmmccmcmcncmeat-remnturccmrcacccaswccrmrmccncu	NULL
P	NULL
8	NULL
G	NULL
8	NULL
L	NULL
v	NULL
T	NULL
A	NULL
f	NULL
BR	NULL
P	NULL
L	NULL
8	NULL
N	NULL
FP	NULL
A	NULL
8	NULL
¥	NULL
P	NULL
Pp	NULL
***	NULL
AVGLSGDSHRASBJLJPOL	NULL
!	NULL

SHTO	NULL
&	NULL
H	NULL
``	NULL
TTGAATGAAGGGTTCTGCTGCT	NULL
GTTGGAAAAACCACCTGATCACAACTTTCTAAGGCAGCTATITTGTTTTGCAA	NULL
TGAGATATTTGCAGTGGTTTCACTAAAGCCTGATCTTCCCACTGGACTGTCGSCCTGTGAGGATGAGGACGTGTCTATCACAGTCAGTAT	NULL
GCCCTGAATGAATGGGTGTCACCCTCCGCCCCCTAGTGAGAGATAAGGACCTCAGGCTCAGAGAGGTTATGTGGTTTTCTCAAAGCCACA	NULL
CAGCAAGATTTGGCAGGTGAGCCTTACTTCTCTTCCTGGGCTAGCCTGCGGTCAGGGGCAAGGCTTTTGGATGATAAGAGTGAGGTGCAG	NULL
TCAGCTCTATATTGGGGSTGGCAGAGGGAAAAGGAGGGGGGGTTCCCAAAGCACCATTCTGCTTTCTGTGAGAAGGGATTTCCCCTCAAC	NULL
AACTTCTGTCCCATTTITCAGAGCTAAAGTGACAAGCCACATCCACGTCCCTGGTTAAAGGTGCTCCCCCTGCAGGAAACACATGTGCAC	NULL
TTGGGATGGAGCCCTCTGTGCGGGAGCGGCTTGCTCACCTCTCAGCCAGTGCCAGCTGGGTGGGTCTCTCCCAGCTCTCGAATCCTAACT	NULL
GCAGCCACCATTTATTCAGCACCTGTTATGTACCAGGCACTTTATGTATCTTATTGCTAACCCTCAAAACAAGCCCTTCCCAACATAAGC	NULL
GCTTTTGTGCCAAACCCATAGGTCTGAAACTGAGACCCAGAGAGGCTGAATGACATGCTCACAGTCACACAGCAGGCAGTGGCAGGCAGT	NULL
AGTGAAGTCGGCTCTATGGATTGTATACCTGGGCTCCTCCAGGCCTCTGCGCTGCCCGGCCTGATACCCTAGCAGGTTGGGTATTCAGAG	NULL
GTGCCTGGGGAGCTTGTTAAAAGTGTAGATTCCAGGCCTCCTTACCCTTAGAGACTGTGACTCAGTATCCGGGGCAGGGCCCAGGCATCT	NULL
TCATTTTGACAGGCCGTCCCGGTGGCTGCCATGCGCAGGCAGGTTTTAGGAACATCATGGGTGGATGATTCCTGGTCTCCCCAGCCCTCT	NULL
TGACCTGGCCACAGAGAGCTGCCTTTCCAGCGAGGTCAGCCGAGATGACGCTGCCGGGAGAGCAGTCTTCTCTGTAGTCCCCGGAGGGGA	NULL
CTCCTCGGAGGAAGGATGAGTCTGAGGGTTCCGGTTGTCTTGGCCTGAGACCACCCAAGGTCTTTTAACAGAAAAAAACTTCACCC	NULL
(	NULL
A	NULL
}	NULL
a	NULL
1	NULL
-	NULL
2	NULL
3	NULL
-	NULL
4	NULL
5	NULL
dl+l+|+l+l+	NULL
wo	NULL
a	NULL
crs	NULL
«	NULL
-	NULL
3915	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1997	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

90	NULL
180	NULL
270	NULL
360	NULL
450	NULL
540	NULL
720	NULL
810	NULL
200	NULL
990	NULL
1080	NULL
1170	NULL
1260	NULL
1350	NULL
1440	NULL
FUSION	NULL
TRANSCRIPTS	NULL
WITH	NULL
EVI	NULL
IN	NULL
LEUKEMIA	NULL
Table	NULL
1	NULL
Primers	NULL
used	NULL
in	NULL
the	NULL
determination	NULL
of	NULL
the	NULL
GR6	NULL
gene	NULL
structure	NULL
and	NULL
in	NULL
the	NULL
identification	NULL
of	NULL
fusion	NULL
transcripts	NULL
Product	NULL
size	NULL
Product	NULL
Primer	NULL
Primer	NULL
(	NULL
bp	NULL
)	NULL
Procedure	NULL
Primer	NULL
(	NULL
s	NULL
)	NULL
(	NULL
5	NULL
'	NULL
to	NULL
3	NULL
``	NULL
)	NULL
nucleotide	NULL
nos	NULL
.	NULL

name	NULL
location	NULL
800	NULL
RACE	NULL
GCATTGTTCTGGGCTCATGGCC	NULL
138-272	NULL
SAC1S5DN	NULL
Exon	NULL
1	NULL
``	NULL
809-1477	NULL
600	NULL
RACE	NULL
CCACCTGATCACAACTTTCTAA	NULL
1488-2091	NULL
SAC13DN2	NULL
Exon	NULL
4	NULL
450	NULL
RACE	NULL
TTCAGCACCTGTTATGCACCAG	NULL
2086-2542	NULL
SAC13DN4	NULL
Exon	NULL
4	NULL
250	NULL
RACE	NULL
CCAGCCCTCTTGACCTGGCCA	NULL
2535-2696	NULL
SACI3DNS	NULL
Exon	NULL
4	NULL
1000	NULL
RACE	NULL
AGAGCCCCAGAGCACGGCAGT	NULL
430-1470	NULL
SAC23YN	NULL
Exon	NULL
3	NULL
600	NULL
RT-PCR	NULL
AGAGCCCCAGAGCACGGCAGT	NULL
430-1027	NULL
SAC23YN	NULL
Exon	NULL
3	NULL
GCTCGTGCTGGAAACCAGCTCA	NULL
GrRea	NULL
``	NULL
Exon	NULL
4	NULL
300	NULL
RT-PCR	NULL
AGAGCCCCAGAGCACGGCAGT	NULL
430-502	NULL
SAC23YN	NULL
Exon	NULL
3	NULL
GCTCGTGCTGGAAACCAGCTCA	NULL
809-1027	NULL
GRéA	NULL
``	NULL
Exon	NULL
4	NULL
350	NULL
RT-PCR	NULL
GCATTGTTCTGGGCTCATGGCC	NULL
138-496	NULL
SACISDN	NULL
Exon	NULL
1	NULL
AGCTCCATGGCCACAGGGATG	NULL
SAC23XN	NULL
Exon	NULL
3	NULL
280	NULL
RT-PCR	NULL
CTGGGAGCCTTCACTCTSCCCA	NULL
211-272	NULL
GReB	NULL
``	NULL
Exon	NULL
1	NULL
GCTCGTCGTGGAAACCAGCTCA	NULL
809-1027	NULL
GrRéa	NULL
``	NULL
Exon	NULL
4	NULL
510	NULL
RT-PCR	NULL
GAAATCGTGCGTGACATTAAG	NULL
ACA	NULL
Actin	NULL
cDNA	NULL
AAGCATTTGCGGTGGACGATGG	NULL
ACB	NULL
Actin	NULL
cDNA	NULL
320	NULL
RT-PCR	NULL
TGCGGTGTGCGAAGCTCGCATTG	NULL
SACISD®	NULL
Exon	NULL
1	NULL
GCAATGTCTGCAACTACTCTA	NULL
EVIK	NULL
EVIL	NULL
exon	NULL
3	NULL
580	NULL
RT-PCR	NULL
TGGTTTCCAGCACGAGCCTG	NULL
GR6AR®	NULL
Exon	NULL
4	NULL
670	NULL
GCAATGTCTGCAACTACTCTA	NULL
EVIK	NULL
EVIL	NULL
exon	NULL
3	NULL
320	NULL
RT-PCR	NULL
GCAATGTCTGCAACTACTCTA	NULL
EVIK	NULL
EVI1	NULL
exon	NULL
3	NULL
ACGTGAAGCGCACAGTGGAC	NULL
RK	NULL
RBPHI	NULL
exon	NULL
1	NULL
``	NULL
Exons	NULL
1-4	NULL
refer	NULL
to	NULL
the	NULL
GR6	NULL
gene	NULL
.	NULL

®	NULL
GR6	NULL
primers	NULL
GR6A	NULL
and	NULL
GR6B	NULL
were	NULL
used	NULL
in	NULL
the	NULL
RT-PCR	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1d	NULL
.	NULL

©	NULL
GR6	NULL
primers	NULL
SACISD	NULL
and	NULL
GR6AR	NULL
were	NULL
used	NULL
with	NULL
the	NULL
EVI1	NULL
primer	NULL
EVIK	NULL
in	NULL
the	NULL
RT-PCR	NULL
experiments	NULL
of	NULL
Fig	NULL
.	NULL

22.	NULL
volume	NULL
of	NULL
20	NULL
p	NULL
}	NULL
were	NULL
incubated	NULL
at	NULL
42°C	NULL
for	NULL
1	NULL
h	NULL
;	NULL
following	NULL
addition	NULL
of	NULL
10	NULL
ug	NULL
of	NULL
RNase	NULL
A	NULL
,	NULL
the	NULL
reaction	NULL
was	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

One	NULL
ul	NULL
of	NULL
the	NULL
reverse	NULL
transcription	NULL
reaction	NULL
was	NULL
used	NULL
in	NULL
each	NULL
PCR	NULL
.	NULL

PCR	NULL
was	NULL
carried	NULL
out	NULL
under	NULL
standard	NULL
conditions	NULL
(	NULL
14	NULL
)	NULL
using	NULL
20	NULL
pmol	NULL
of	NULL
each	NULL
gene-specific	NULL
primer	NULL
and	NULL
the	NULL
following	NULL
cycling	NULL
conditions	NULL
:	NULL
95°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
55°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
2	NULL
min	NULL
for	NULL
30	NULL
cycles	NULL
for	NULL
all	NULL
primer	NULL
pairs	NULL
,	NULL
except	NULL
those	NULL
for	NULL
actin	NULL
,	NULL
for	NULL
which	NULL
only	NULL
17	NULL
cycles	NULL
were	NULL
used	NULL
.	NULL

All	NULL
primer	NULL
sequences	NULL
are	NULL
listed	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

For	NULL
amplification	NULL
of	NULL
actin	NULL
,	NULL
primers	NULL
were	NULL
ACA	NULL
and	NULL
ACB	NULL
;	NULL
for	NULL
GR6	NULL
,	NULL
GR6A	NULL
and	NULL
GR6B	NULL
;	NULL
for	NULL
exons	NULL
1	NULL
and	NULL
4	NULL
of	NULL
GR6	NULL
,	NULL
GR6GD	NULL
and	NULL
GR6AR	NULL
;	NULL
for	NULL
exon	NULL
1	NULL
of	NULL
RBPH1	NULL
,	NULL
RK	NULL
;	NULL
and	NULL
for	NULL
exon	NULL
3	NULL
of	NULL
EVI1	NULL
,	NULL
EVIK	NULL
.	NULL

RT-PCR	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
fusion	NULL
transcripts	NULL
was	NULL
performed	NULL
using	NULL
primer	NULL
pairs	NULL
SAC15D	NULL
and	NULL
EVIK	NULL
,	NULL
GR6AR	NULL
and	NULL
EVIK	NULL
,	NULL
and	NULL
RK	NULL
and	NULL
EVIK	NULL
.	NULL

Products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
Hybond	NULL
N+	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
the	NULL
appropriate	NULL
probe	NULL
.	NULL

Cloning	NULL
of	NULL
GR6-EVI1	NULL
and	NULL
RBPH1	NULL
Fusion	NULL
Transcripts	NULL
.	NULL

PCR	NULL
products	NULL
of	NULL
320	NULL
bp	NULL
with	NULL
EVIK	NULL
and	NULL
SACI15D	NULL
primers	NULL
,	NULL
580-	NULL
and	NULL
670-bp	NULL
products	NULL
with	NULL
GR6AR	NULL
and	NULL
EVIK	NULL
primers	NULL
,	NULL
and	NULL
a	NULL
320-bp	NULL
product	NULL
with	NULL
EVIK	NULL
and	NULL
RK	NULL
primers	NULL
were	NULL
gel-purified	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
pCR2.1	NULL
vector	NULL
using	NULL
the	NULL
TA	NULL
cloning	NULL
kit	NULL
(	NULL
Invitrogen	NULL
)	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
directions	NULL
.	NULL

Sequencing	NULL
was	NULL
performed	NULL
using	NULL
Applied	NULL
Biosystems	NULL
model	NULL
373A	NULL
automated	NULL
DNA	NULL
sequencer	NULL
using	NULL
dye	NULL
terminator	NULL
reactions	NULL
.	NULL

RACE	NULL
.	NULL

Oligo	NULL
(	NULL
dT	NULL
)	NULL
-primed	NULL
double-stranded	NULL
cDNA	NULL
was	NULL
synthesized	NULL
using	NULL
procedures	NULL
and	NULL
reagents	NULL
from	NULL
the	NULL
Marathon	NULL
RACE	NULL
cDNA	NULL
amplification	NULL
kit	NULL
{	NULL
Clontech	NULL
)	NULL
.	NULL

Purified	NULL
cDNA	NULL
was	NULL
ligated	NULL
to	NULL
Marathon	NULL
adapters	NULL
(	NULL
Clontech	NULL
)	NULL
.	NULL

3	NULL
'	NULL
and	NULL
5°	NULL
RACE	NULL
products	NULL
were	NULL
generated	NULL
by	NULL
long	NULL
PCR	NULL
using	NULL
various	NULL
gene-specific	NULL
primers	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
and	NULL
the	NULL
API	NULL
Marathon	NULL
primer	NULL
.	NULL

To	NULL
increase	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
procedure	NULL
,	NULL
the	NULL
second	NULL
PCR	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
nested	NULL
gene-specific	NULL
primers	NULL
and	NULL
the	NULL
AP2	NULL
Marathon	NULL
primer	NULL
.	NULL

PCRs	NULL
used	NULL
the	NULL
Expand	NULL
long-template	NULL
PCR	NULL
system	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
with	NULL
30	NULL
cycles	NULL
of	NULL
94°C	NULL
for	NULL
30	NULL
s	NULL
,	NULL
60°C	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
68°C	NULL
for	NULL
4	NULL
min	NULL
.	NULL

RACE	NULL
products	NULL
were	NULL
electrophoresed	NULL
,	NULL
identified	NULL
by	NULL
hybridization	NULL
,	NULL
and	NULL
cloned	NULL
as	NULL
above	NULL
.	NULL

Results	NULL
Characterization	NULL
of	NULL
the	NULL
GR6	NULL
Gene	NULL
.	NULL

A	NULL
previous	NULL
report	NULL
described	NULL
gene	NULL
identification	NULL
within	NULL
an	NULL
80-kb	NULL
segment	NULL
of	NULL
3q21	NULL
,	NULL
spanning	NULL
a	NULL
number	NULL
of	NULL
leukemia	NULL
breakpoints	NULL
(	NULL
9	NULL
)	NULL
.	NULL

As	NULL
part	NULL
of	NULL
this	NULL
work	NULL
,	NULL
a	NULL
25-kb	NULL
segment	NULL
surrounding	NULL
the	NULL
breakpoint	NULL
from	NULL
the	NULL
leukemia-derived	NULL
cell	NULL
line	NULL
UCSD-AML1	NULL
was	NULL
completely	NULL
sequenced	NULL
.	NULL

Analysis	NULL
of	NULL
this	NULL
sequence	NULL
using	NULL
the	NULL
GRAIL	NULL
exon	NULL
identification	NULL
software	NULL
predicted	NULL
three	NULL
exons	NULL
,	NULL
located	NULL
approximately	NULL
1	NULL
kb	NULL
telomeric	NULL
to	NULL
the	NULL
UCSD-AML	NULL
breakpoint	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Sequences	NULL
of	NULL
the	NULL
predicted	NULL
exons	NULL
were	NULL
used	NULL
to	NULL
design	NULL
primers	NULL
for	NULL
RACE	NULL
and	NULL
RT-PCR	NULL
experiments	NULL
(	NULL
described	NULL
be-low	NULL
)	NULL
.	NULL

Comparisons	NULL
of	NULL
these	NULL
results	NULL
with	NULL
the	NULL
genomic	NULL
sequence	NULL
deter	NULL
mined	NULL
exact	NULL
exon	NULL
boundaries	NULL
and	NULL
the	NULL
complete	NULL
structure	NULL
of	NULL
the	NULL
gene	NULL
,	NULL
which	NULL
we	NULL
have	NULL
called	NULL
GR6	NULL
.	NULL

GR6	NULL
is	NULL
composed	NULL
of	NULL
4	NULL
exons	NULL
(	NULL
Fig	NULL
.	NULL

16	NULL
)	NULL
:	NULL
exon	NULL
1	NULL
,	NULL
of	NULL
undetermined	NULL
length	NULL
(	NULL
RACE	NULL
has	NULL
not	NULL
been	NULL
extended	NULL
further	NULL
5	NULL
'	NULL
)	NULL
,	NULL
and	NULL
exons	NULL
2-4	NULL
,	NULL
of	NULL
121	NULL
bp	NULL
,	NULL
109	NULL
bp	NULL
,	NULL
and	NULL
1.6	NULL
kb	NULL
,	NULL
respectively	NULL
.	NULL

Cloning	NULL
and	NULL
sequencing	NULL
of	NULL
the	NULL
following	NULL
RT-PCR	NULL
and	NULL
RACE	NULL
products	NULL
determined	NULL
this	NULL
structure	NULL
:	NULL
(	NULL
a	NULL
)	NULL
an	NULL
800-bp	NULL
RACE	NULL
product	NULL
contained	NULL
part	NULL
of	NULL
exon	NULL
1	NULL
,	NULL
spliced	NULL
directly	NULL
to	NULL
exon	NULL
4	NULL
;	NULL
(	NULL
b	NULL
)	NULL
three	NULL
consecutive	NULL
3	NULL
'	NULL
RACE	NULL
products	NULL
of	NULL
600	NULL
,	NULL
450	NULL
,	NULL
and	NULL
250	NULL
bp	NULL
connected	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
800-bp	NULL
RACE	NULL
product	NULL
with	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tail	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

The	NULL
250-bp	NULL
RACE	NULL
product	NULL
contained	NULL
a	NULL
30-nucleotide	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tail	NULL
that	NULL
was	NULL
not	NULL
encoded	NULL
by	NULL
the	NULL
genomic	NULL
sequence	NULL
;	NULL
(	NULL
c	NULL
)	NULL
a	NULL
1.0-kb	NULL
RACE	NULL
product	NULL
and	NULL
a	NULL
600-bp	NULL
RT-PCR	NULL
product	NULL
contained	NULL
part	NULL
of	NULL
exon	NULL
3	NULL
,	NULL
the	NULL
entire	NULL
exon	NULL
3a	NULL
,	NULL
and	NULL
part	NULL
of	NULL
exon	NULL
4	NULL
;	NULL
(	NULL
d	NULL
)	NULL
a	NULL
300-bp	NULL
RT-PCR	NULL
product	NULL
contained	NULL
part	NULL
of	NULL
exon	NULL
3	NULL
,	NULL
spliced	NULL
directly	NULL
to	NULL
exon	NULL
4	NULL
;	NULL
and	NULL
(	NULL
e	NULL
)	NULL
a	NULL
350-bp	NULL
RT-PCR	NULL
product	NULL
contained	NULL
part	NULL
of	NULL
exon	NULL
1	NULL
,	NULL
the	NULL
entire	NULL
exon	NULL
2	NULL
,	NULL
plus	NULL
part	NULL
of	NULL
exon	NULL
3	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
the	NULL
existence	NULL
of	NULL
several	NULL
alternatively	NULL
spliced	NULL
GR6	NULL
mRNAs	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
b	NULL
and	NULL
c	NULL
)	NULL
:	NULL
an	NULL
mRNA	NULL
in	NULL
which	NULL
exon	NULL
1	NULL
is	NULL
spliced	NULL
directly	NULL
to	NULL
exon	NULL
4	NULL
;	NULL
an	NULL
mRNA	NULL
in	NULL
which	NULL
exons	NULL
3	NULL
and	NULL
4	NULL
are	NULL
connected	NULL
through	NULL
exon	NULL
3a	NULL
;	NULL
and	NULL
either	NULL
an	NULL
mRNA	NULL
in	NULL
which	NULL
exons	NULL
1-4	NULL
are	NULL
spliced	NULL
in	NULL
sequence	NULL
or	NULL
two	NULL
mRNAs	NULL
,	NULL
one	NULL
in	NULL
which	NULL
exons	NULL
1-3	NULL
are	NULL
spliced	NULL
in	NULL
sequence	NULL
and	NULL
one	NULL
in	NULL
which	NULL
exons	NULL
3	NULL
and	NULL
4	NULL
are	NULL
spliced	NULL
in	NULL
sequence	NULL
(	NULL
these	NULL
last	NULL
two	NULL
mRNAs	NULL
can	NULL
not	NULL
be	NULL
distinguished	NULL
in	NULL
the	NULL
experiments	NULL
described	NULL
here	NULL
)	NULL
.	NULL

All	NULL
splice	NULL
sites	NULL
conform	NULL
to	NULL
the	NULL
consensus	NULL
GT/AG	NULL
.	NULL

The	NULL
RT-PCR	NULL
product	NULL
for	NULL
the	NULL
first	NULL
transcript	NULL
(	NULL
in	NULL
which	NULL
exon	NULL
1	NULL
of	NULL
GR6	NULL
is	NULL
spliced	NULL
directly	NULL
into	NULL
exon	NULL
4	NULL
)	NULL
was	NULL
always	NULL
much	NULL
more	NULL
intense	NULL
than	NULL
the	NULL
other	NULL
two	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
is	NULL
the	NULL
major	NULL
normal	NULL
GR6	NULL
transcript	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
identification	NULL
by	NULL
RACE	NULL
of	NULL
only	NULL
this	NULL
transcript	NULL
(	NULL
the	NULL
other	NULL
two	NULL
were	NULL
identified	NULL
by	NULL
RT-PCR	NULL
)	NULL
.	NULL

Exon	NULL
4	NULL
contains	NULL
a	NULL
450-bp	NULL
ORF	NULL
,	NULL
with	NULL
the	NULL
initiation	NULL
methionine	NULL
at	NULL
nucleotide	NULL
968	NULL
(	NULL
Fig	NULL
.	NULL

1c	NULL
)	NULL
.	NULL

No	NULL
homologies	NULL
to	NULL
known	NULL
genes	NULL
,	NULL
expressed	NULL
sequence	NULL
tags	NULL
,	NULL
or	NULL
other	NULL
sequences	NULL
were	NULL
found	NULL
in	NULL
Blast	NULL
searches	NULL
with	NULL
the	NULL
GR6	NULL
transcripts	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
a	NULL
50-bp	NULL
Alu	NULL
segment	NULL
within	NULL
exon	NULL
2	NULL
.	NULL

All	NULL
hybridizations	NULL
to	NULL
Northern	NULL
blots	NULL
containing	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
+	NULL
RNA	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
fetal	NULL
and	NULL
adult	NULL
tissues	NULL
and	NULL
several	NULL
cancer	NULL
cell	NULL
lines	NULL
and	NULL
using	NULL
RACE	NULL
and	NULL
RT-PCR	NULL
products	NULL
as	NULL
probes	NULL
were	NULL
negative	NULL
.	NULL

Normal	NULL
GR6	NULL
Expression	NULL
and	NULL
Activation	NULL
in	NULL
Leukemia	NULL
.	NULL

The	NULL
negative	NULL
Northern	NULL
results	NULL
suggested	NULL
GR6	NULL
may	NULL
be	NULL
expressed	NULL
only	NULL
at	NULL
low	NULL
3916	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1997	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

FUSION	NULL
TRANSCRIPTS	NULL
WITH	NULL
EVIL	NULL
IN	NULL
LEUKEMIA	NULL
1	NULL
2	NULL
a	NULL
-	NULL
=	NULL
4+	NULL
1	NULL
+	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Intergenic	NULL
fusions	NULL
of	NULL
GR6	NULL
and	NULL
RBPHI1	NULL
with	NULL
EVI1	NULL
.	NULL

a	NULL
,	NULL
RT-PCR	NULL
identifying	NULL
the	NULL
intergenic	NULL
transcripts	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
primers	NULL
GR6D	NULL
and	NULL
EVIK	NULL
producing	NULL
IT1	NULL
;	NULL
Lane	NULL
2	NULL
,	NULL
primers	NULL
GR6AR	NULL
and	NULL
EVIK	NULL
,	NULL
<	NULL
pzm	NULL
3	NULL
+0	NULL
-	NULL
600	NULL
bp	NULL
UCSD-AML1	NULL
breakpoint	NULL
-	NULL
300	NULL
bp	NULL
producing	NULL
upper	NULL
band	NULL
,	NULL
IT2	NULL
,	NULL
and	NULL
lower	NULL
band	NULL
,	NULL
IT3	NULL
;	NULL
Lane	NULL
3	NULL
,	NULL
primers	NULL
RBPH1	NULL
RK	NULL
and	NULL
EVIK	NULL
producing	NULL
1T4	NULL
.	NULL

+	NULL
,	NULL
with	NULL
reverse	NULL
transcriptase	NULL
;	NULL
-	NULL
,	NULL
without	NULL
reverse	NULL
transcriptase	NULL
.	NULL

b	NULL
,	NULL
positions	NULL
and	NULL
orientations	NULL
of	NULL
GR6	NULL
,	NULL
P2	NULL
,	NULL
and	NULL
RBPH1	NULL
relative	NULL
to	NULL
EVI	NULL
!	NULL

in	NULL
the	NULL
der	NULL
3q+	NULL
chromosome	NULL
of	NULL
the	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
in	NULL
the	NULL
UCSD-AML	NULL
1	NULL
cell	NULL
line	NULL
are	NULL
shown	NULL
.	NULL

RBPH	NULL
]	NULL
T	NULL
is	NULL
composed	NULL
of	NULL
10	NULL
exons	NULL
(	NULL
20	NULL
)	NULL
;	NULL
only	NULL
exon	NULL
one	NULL
is	NULL
indicated	NULL
sepa-rately	NULL
.	NULL

The	NULL
four	NULL
exons	NULL
of	NULL
GR6	NULL
are	NULL
indicated	NULL
.	NULL

Only	NULL
exons	NULL
1-3	NULL
of	NULL
EVI1	NULL
are	NULL
shown	NULL
.	NULL

MB	NULL
,	NULL
segments	NULL
of	NULL
exons	NULL
2	NULL
and	NULL
3	NULL
that	NULL
are	NULL
not	NULL
translated	NULL
in	NULL
the	NULL
EVI	NULL
!	NULL

-alone	NULL
protein	NULL
.	NULL

The	NULL
novel	NULL
exon	NULL
X	NULL
is	NULL
located	NULL
in	NULL
3q26	NULL
,	NULL
5	NULL
'	NULL
to	NULL
the	NULL
EVII	NULL
gene	NULL
.	NULL

The	NULL
four	NULL
intergenic	NULL
transcripts	NULL
are	NULL
indicated	NULL
.	NULL

c	NULL
,	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
IT1-IT4	NULL
fusions	NULL
.	NULL

Ftalicized	NULL
letters	NULL
,	NULL
GR6	NULL
sequences	NULL
in	NULL
ITl-IT3	NULL
;	NULL
underlined	NULL
letters	NULL
,	NULL
exon	NULL
X	NULL
sequence	NULL
in	NULL
IT3	NULL
.	NULL

IT4	NULL
is	NULL
the	NULL
RBPHI1	NULL
fusion	NULL
transcript	NULL
.	NULL

Boldface	NULL
let	NULL
ITl	NULL
IT2	NULL
ters	NULL
,	NULL
translation	NULL
of	NULL
EVI1	NULL
exons	NULL
2	NULL
and	NULL
3	NULL
common	NULL
to	NULL
IT4	NULL
IT1-IT4	NULL
;	NULL
underlined	NULL
,	NULL
italicized	NULL
letters	NULL
,	NULL
continuation	NULL
c	NULL
of	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
EVI1	NULL
sequence	NULL
.	NULL

ITl	NULL
MASPVPTMCQDSAVPLWAFPH	NULL
50	NULL
IT3	NULL
MASPVPTMCQDSAVPLWAFPHPSLPDIKLRFPAVFLEAVGKSGDSHRASE	NULL
MEAPAAGLFLLLLLGTWAPAPGSASSEAPPLINEDVKRTVDLSSH	NULL
MTQILDEFYNV	NULL
100	NULL
IT2	NULL
PSLPDIKLRFPAVFLEAVGKSGDSHRASEQLCFQLFSMTQSWILDEF	NULL
YXNV	NULL
IT3	NULL
QLCFQLFSMTOSWVCPYPLNSELLAOGICKYPGOTPEDGSVEKILDEF	NULL
YNV	NULL
IT4	NULL
LAKVTAEVVLAHLGGGSTSRATSFLLALEPELEARLAHLGVQILDEFYNV	NULL
KFCIDASQPDVGSWLKYIRFAGCYDQHNLVACQINDQIFYRVVADIAPG	NULL
150	NULL
KFCIDASQPDVGSWLKYIRFAGCYDQHNLVACQINDQIFYRVVADIAPG	NULL
KFCIDASQPDVGSWLKYIRFAGCYDQHNLVACQINDQIFYRVVADIAPG	NULL
KFCIDASQPDVGSWLKYIRFAGCYDQHNLVACQINDQIFYRVVADIAPG	NULL
EELLLFMKSEDYPHETMAPDIHEEROYRCEDCDOLFESKAELADHOKFPC_	NULL
200	NULL
EELLLF	NULL
continued	NULL
with	NULL
the	NULL
ITl	NULL
sequence	NULL
EELLLF	NULL
continued	NULL
with	NULL
the	NULL
ITl	NULL
sequence	NULL
EELLLF	NULL
continued	NULL
with	NULL
the	NULL
ITl	NULL
sequence	NULL
STPHSAFSMVEEDFOQOK	NULL
_	NULL
continued	NULL
with	NULL
the	NULL
EVIl	NULL
sequence	NULL
(	NULL
11	NULL
)	NULL
levels	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
was	NULL
used	NULL
to	NULL
explore	NULL
this	NULL
possibility	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

RT-PCR	NULL
using	NULL
GRG6A	NULL
and	NULL
GRG6B	NULL
primers	NULL
(	NULL
within	NULL
exons	NULL
1	NULL
and	NULL
4	NULL
,	NULL
respectively	NULL
)	NULL
was	NULL
weak	NULL
in	NULL
normal	NULL
lymphocytes	NULL
and	NULL
negative	NULL
in	NULL
a	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
(	NULL
Lanes	NULL
/	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Results	NULL
were	NULL
similar	NULL
with	NULL
other	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
both	NULL
normal	NULL
and	NULL
tumor-derived	NULL
cell	NULL
lines	NULL
lacking	NULL
3q21	NULL
rearrangements	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
normal	NULL
human	NULL
7-8-week	NULL
embryo	NULL
showed	NULL
strong	NULL
levels	NULL
of	NULL
GR6	NULL
product	NULL
(	NULL
Lane	NULL
4	NULL
)	NULL
.	NULL

This	NULL
is	NULL
the	NULL
only	NULL
evidence	NULL
of	NULL
GR6	NULL
expression	NULL
in	NULL
material	NULL
carrying	NULL
a	NULL
normal	NULL
3q21	NULL
region	NULL
that	NULL
we	NULL
have	NULL
found	NULL
.	NULL

GR6	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
the	NULL
UCSD-AML1	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
,	NULL
in	NULL
which	NULL
the	NULL
3q21	NULL
breakpoint	NULL
lies	NULL
approximately	NULL
1	NULL
kb	NULL
3	NULL
'	NULL
to	NULL
GR6	NULL
.	NULL

In	NULL
neither	NULL
fetal	NULL
tissues	NULL
nor	NULL
the	NULL
UCSD-AML1	NULL
cell	NULL
line	NULL
is	NULL
GRG6	NULL
expression	NULL
detectable	NULL
by	NULL
Northern	NULL
analysis	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
patient	NULL
material	NULL
that	NULL
showed	NULL
a	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
(	NULL
q21	NULL
;	NULL
q426	NULL
)	NULL
(	NULL
sample	NULL
no	NULL
.	NULL

32	NULL
;	NULL
Lane	NULL
5	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
breakpoints	NULL
outside	NULL
the	NULL
GR6	NULL
gene	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
UCSD-AML1	NULL
breakpoint	NULL
is	NULL
3	NULL
'	NULL
to	NULL
GR6	NULL
and	NULL
the	NULL
sample	NULL
no	NULL
.	NULL

32	NULL
breakpoint	NULL
is	NULL
5	NULL
'	NULL
(	NULL
see	NULL
Discussion	NULL
and	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
can	NULL
both	NULL
effect	NULL
aberrant	NULL
activation	NULL
of	NULL
GR6	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
with	NULL
breakpoints	NULL
surrounding	NULL
the	NULL
EVIL	NULL
gene	NULL
in	NULL
3q26	NULL
.	NULL

Identification	NULL
of	NULL
GR6-EVI1	NULL
and	NULL
RBPH1-EVI1	NULL
Fusion	NULL
Transcripts	NULL
in	NULL
the	NULL
UCSD-AML1	NULL
Cell	NULL
Line	NULL
.	NULL

Fusion	NULL
transcripts	NULL
involving	NULL
the	NULL
EVIL	NULL
gene	NULL
have	NULL
been	NULL
reported	NULL
in	NULL
cases	NULL
of	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q26	NULL
;	NULL
q22	NULL
)	NULL
(	NULL
15	NULL
)	NULL
and	NULL
t	NULL
(	NULL
3	NULL
;	NULL
12	NULL
)	NULL
(	NULL
q26	NULL
;	NULL
p13	NULL
)	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Fusions	NULL
have	NULL
most	NULL
frequently	NULL
involved	NULL
splicing	NULL
into	NULL
exon	NULL
2	NULL
of	NULL
Fig	NULL
.	NULL

2b	NULL
shows	NULL
that	NULL
the	NULL
positions	NULL
and	NULL
3917	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1997	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

FUSION	NULL
TRANSCRIPTS	NULL
WITH	NULL
EVI	NULL
IN	NULL
LEUKEMIA	NULL
6°	NULL
__	NULL
194	NULL
i	NULL
*wos	NULL
``	NULL
ear	NULL
|	NULL
1	NULL
der	NULL
3q-1	NULL
.	NULL

(	NULL
3:3	NULL
<	NULL
hr	NULL
--	NULL
-I	NULL
«	NULL
f	NULL
--	NULL
-wesp	NULL
amt	NULL
*E	NULL
j°	NULL
ane	NULL
:	NULL
72612	NULL
>	NULL
A	NULL
?	NULL

*	NULL
*	NULL
heen	NULL
der	NULL
3q+	NULL
I	NULL
F10	NULL
«	NULL
th-	NULL
«	NULL
<	NULL
--	NULL
-1D	NULL
4	NULL
GR6	NULL
[	NULL
|	NULL
EAP	NULL
I	NULL
der	NULL
3q-2.1	NULL
(	NULL
3:3	NULL
)	NULL
1	NULL
MUC	NULL
Enr	NULL
os	NULL
0	NULL
q	NULL
_	NULL
sok	NULL
zo	NULL
4	NULL
*	NULL
<	NULL
rhern	NULL
der	NULL
3q+	NULL
I	NULL
e	NULL
rcs	NULL
~*	NULL
®	NULL
*	NULL
(	NULL
mps	NULL
)	NULL
<	NULL
ap	NULL
U	NULL
7	NULL
der	NULL
3q-Fig	NULL
.	NULL

3	NULL
.	NULL

Positions	NULL
and	NULL
orientations	NULL
of	NULL
3q21	NULL
and	NULL
3.	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
<	NULL
€	NULL
.	NULL

€	NULL
.	NULL

Pa	NULL
€	NULL
3q26	NULL
genes	NULL
relative	NULL
to	NULL
breakpoints	NULL
in	NULL
1	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
,	NULL
t	NULL
(	NULL
1	NULL
;	NULL
3	NULL
)	NULL
.	NULL

UB2/	NULL
#	NULL
32	NULL
EVI	NULL
(	NULL
MDS	NULL
)	NULL
1	NULL
P2	NULL
A	NULL
?	NULL

4	NULL
RBPH	NULL
and	NULL
inv	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Genes	NULL
in	NULL
3q21	NULL
include	NULL
1D4	NULL
,	NULL
GR6	NULL
,	NULL
2C12	NULL
I	NULL
der	NULL
3q+	NULL
(	NULL
GR2	NULL
)	NULL
,	NULL
P2	NULL
,	NULL
and	NULL
FIO	NULL
and	NULL
Ap4	NULL
are	NULL
previously	NULL
described	NULL
Notl-linking	NULL
clones	NULL
(	NULL
8	NULL
)	NULL
.	NULL

EVI	NULL
,	NULL
MDS1	NULL
,	NULL
and	NULL
the	NULL
gene	NULL
encoding	NULL
ElA-associated	NULL
pro-	NULL
F10	NULL
G-	NULL
--	NULL
-J	NULL
»	NULL
{	NULL
--	NULL
_	NULL
L	NULL
--	NULL
<	NULL
--	NULL
-tein	NULL
in	NULL
3q26	NULL
have	NULL
been	NULL
described	NULL
(	NULL
6	NULL
,	NULL
15	NULL
)	NULL
.	NULL

(	NULL
MDS	NULL
)	NULL
,	NULL
|	NULL
104	NULL
GR6	NULL
-	NULL
2012	NULL
P2	NULL
J	NULL
(	NULL
MDS	NULL
)	NULL
EAP	NULL
der	NULL
3q-uncertainty	NULL
in	NULL
the	NULL
placement	NULL
of	NULL
the	NULL
MDS/	NULL
gene	NULL
||	NULL
relative	NULL
to	NULL
the	NULL
breakpoint	NULL
.	NULL

Breakpoints	NULL
have	NULL
been	NULL
__	NULL
4.	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
<	NULL
4	NULL
€	NULL
AP	NULL
4	NULL
£	NULL
described	NULL
previously	NULL
(	NULL
7-9	NULL
,	NULL
19	NULL
)	NULL
.	NULL

*	NULL
JD	NULL
EVI	NULL
(	NULL
MDS	NULL
)	NULL
1	NULL
I	NULL
__	NULL
der	NULL
3q+	NULL
1	NULL
F101D4	NULL
ERG	NULL
20i2	NULL
$	NULL
2	NULL
[	NULL
|	NULL
1	NULL
p36	NULL
der	NULL
3	NULL
er	NULL
5.1	NULL
(	NULL
1	NULL
;	NULL
3	NULL
)	NULL
I	NULL
»	NULL
AP	NULL
4	NULL
<	NULL
--	NULL
-	NULL
#	NULL
34	NULL
1	NULL
p36	NULL
[	NULL
|	NULL
|	NULL
RBPH	NULL
deri	NULL
I	NULL
F10	NULL
<	NULL
--	NULL
-	NULL
ﬂ	NULL
--	NULL
I	NULL
»	NULL
6.	NULL
inv	NULL
(	NULL
3	NULL
)	NULL
|	NULL
1D4	NULL
GR6	NULL
1	NULL
44	NULL
RBP	NULL
P2	NULL
E12	NULL
[	NULL
|	NULL
EV|	NULL
MDS	NULL
EAP	NULL
3	NULL
cases	NULL
1	NULL
//	NULL
1	NULL
7.	NULL
inv	NULL
(	NULL
3	NULL
)	NULL
F10104	NULL
R6	NULL
-	NULL
2012	NULL
P2	NULL
L	NULL
_	NULL
//	NULL
RBP	NULL
1	NULL
VI	NULL
MDS	NULL
EAP	NULL
locations	NULL
of	NULL
GR6	NULL
,	NULL
a	NULL
previously	NULL
described	NULL
novel	NULL
gene	NULL
,	NULL
P2	NULL
(	NULL
9	NULL
)	NULL
,	NULL
and	NULL
RBPH1	NULL
(	NULL
10	NULL
)	NULL
in	NULL
3q21	NULL
have	NULL
the	NULL
same	NULL
orientation	NULL
as	NULL
the	NULL
EVI	NULL
!	NULL

gene	NULL
in	NULL
3q26	NULL
in	NULL
the	NULL
UCSD-AML	NULL
cell	NULL
line	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
GR6	NULL
,	NULL
P2	NULL
,	NULL
and	NULL
RBPH1	NULL
could	NULL
,	NULL
in	NULL
principle	NULL
,	NULL
participate	NULL
in	NULL
forming	NULL
intergenic	NULL
fusion	NULL
transcripts	NULL
with	NULL
EVI1	NULL
.	NULL

To	NULL
explore	NULL
this	NULL
possibility	NULL
,	NULL
RT-PCR	NULL
was	NULL
carried	NULL
out	NULL
between	NULL
exon	NULL
3	NULL
of	NULL
the	NULL
EVIZZ	NULL
gene	NULL
and	NULL
various	NULL
exons	NULL
of	NULL
GR6	NULL
and	NULL
RBPH1	NULL
and	NULL
segments	NULL
of	NULL
the	NULL
P2	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
)	NULL
.	NULL

Three	NULL
different	NULL
intergenic	NULL
transcripts	NULL
between	NULL
EVIl	NULL
and	NULL
GR6	NULL
and	NULL
one	NULL
intergenic	NULL
transcript	NULL
between	NULL
EVI1	NULL
and	NULL
RBPH1	NULL
were	NULL
identified	NULL
:	NULL
(	NULL
a	NULL
)	NULL
IT	NULL
]	NULL
fuses	NULL
exon	NULL
1	NULL
of	NULL
the	NULL
GR6	NULL
gene	NULL
with	NULL
exon	NULL
2	NULL
of	NULL
the	NULL
EVI	NULL
]	NULL
gene	NULL
.	NULL

The	NULL
ORF	NULL
of	NULL
this	NULL
transcript	NULL
includes	NULL
3	NULL
amino	NULL
acids	NULL
(	NULL
including	NULL
methionine	NULL
)	NULL
of	NULL
exon	NULL
1	NULL
of	NULL
the	NULL
GR6	NULL
gene	NULL
,	NULL
63	NULL
amino	NULL
acids	NULL
of	NULL
exons	NULL
2	NULL
and	NULL
3	NULL
of	NULL
the	NULL
EVIL	NULL
gene	NULL
(	NULL
in	NULL
normal	NULL
EVIl	NULL
transcripts	NULL
this	NULL
region	NULL
is	NULL
not	NULL
translated	NULL
;	NULL
Ref	NULL
.	NULL

5	NULL
)	NULL
,	NULL
and	NULL
1051	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
normal	NULL
EVI	NULL
}	NULL
protein	NULL
.	NULL

(	NULL
b	NULL
)	NULL
IT2	NULL
fuses	NULL
exon	NULL
4	NULL
of	NULL
the	NULL
GR6	NULL
gene	NULL
with	NULL
exon	NULL
2	NULL
of	NULL
the	NULL
EVI	NULL
!	NULL

gene	NULL
.	NULL

An	NULL
ORF	NULL
of	NULL
this	NULL
transcript	NULL
includes	NULL
63	NULL
amino	NULL
acids	NULL
of	NULL
exon	NULL
4	NULL
of	NULL
the	NULL
GR6	NULL
gene	NULL
(	NULL
including	NULL
methionine	NULL
)	NULL
and	NULL
the	NULL
same	NULL
1104	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
EVI	NULL
!	NULL

gene	NULL
as	NULL
IT1	NULL
.	NULL

The	NULL
63	NULL
amino	NULL
acids	NULL
from	NULL
the	NULL
GR6	NULL
gene	NULL
in	NULL
this	NULL
transcript	NULL
are	NULL
encoded	NULL
by	NULL
an	NULL
ORF	NULL
different	NULL
from	NULL
the	NULL
major	NULL
GR6	NULL
ORF	NULL
.	NULL

This	NULL
smaller	NULL
ORF	NULL
is	NULL
200	NULL
bp	NULL
in	NULL
size	NULL
(	NULL
Fig	NULL
.	NULL

Ic	NULL
)	NULL
.	NULL

(	NULL
c	NULL
)	NULL
IT3	NULL
also	NULL
fuses	NULL
exon	NULL
4	NULL
of	NULL
the	NULL
GR6	NULL
gene	NULL
with	NULL
exon	NULL
2	NULL
of	NULL
the	NULL
EVI/	NULL
gene	NULL
.	NULL

But	NULL
in	NULL
this	NULL
case	NULL
,	NULL
an	NULL
87-bp	NULL
exon	NULL
X	NULL
is	NULL
located	NULL
between	NULL
these	NULL
two	NULL
exons	NULL
.	NULL

The	NULL
ORF	NULL
of	NULL
the	NULL
IT3	NULL
is	NULL
the	NULL
same	NULL
as	NULL
the	NULL
ORF	NULL
of	NULL
the	NULL
IT2	NULL
,	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
29	NULL
amino	NULL
acids	NULL
encoded	NULL
by	NULL
exon	NULL
X.	NULL
Exon	NULL
X	NULL
has	NULL
been	NULL
localized	NULL
to	NULL
3q26	NULL
by	NULL
analysis	NULL
of	NULL
a	NULL
chromosome	NULL
3	NULL
hybrid	NULL
mapping	NULL
panel	NULL
(	NULL
Ref	NULL
.	NULL

8	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
it	NULL
is	NULL
not	NULL
part	NULL
of	NULL
the	NULL
published	NULL
sequence	NULL
of	NULL
the	NULL
EVI	NULL
]	NULL
cDNA	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
it	NULL
shows	NULL
no	NULL
homology	NULL
to	NULL
any	NULL
GenBank	NULL
sequences	NULL
in	NULL
Blast	NULL
searches	NULL
.	NULL

(	NULL
d	NULL
)	NULL
1T4	NULL
fuses	NULL
inframe	NULL
exon	NULL
1	NULL
of	NULL
RBPHT	NULL
to	NULL
exon	NULL
2	NULL
of	NULL
EVII	NULL
.	NULL

The	NULL
ORF	NULL
of	NULL
IT4	NULL
contains	NULL
87	NULL
amino	NULL
acids	NULL
of	NULL
RBPH1	NULL
fused	NULL
to	NULL
the	NULL
same	NULL
1104	NULL
amino	NULL
acids	NULL
of	NULL
EVI1	NULL
.	NULL

The	NULL
predicted	NULL
protein	NULL
sequences	NULL
of	NULL
all	NULL
four	NULL
fusion	NULL
proteins	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2¢	NULL
.	NULL

Summary	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
complexity	NULL
of	NULL
these	NULL
data	NULL
,	NULL
some	NULL
additional	NULL
details	NULL
are	NULL
worth	NULL
summarizing	NULL
.	NULL

No	NULL
intergenic	NULL
fusion	NULL
transcripts	NULL
involving	NULL
P2	NULL
or	NULL
any	NULL
other	NULL
exons	NULL
of	NULL
GR6	NULL
or	NULL
RBPH	NULL
!	NULL

T	NULL
were	NULL
found	NULL
,	NULL
and	NULL
RBPH1-GR6-EVIl	NULL
tandem	NULL
fusions	NULL
were	NULL
not	NULL
seen	NULL
.	NULL

Limited	NULL
patient	NULL
material	NULL
precluded	NULL
testing	NULL
of	NULL
sample	NULL
no	NULL
.	NULL

32	NULL
for	NULL
any	NULL
fusion	NULL
transcripts	NULL
.	NULL

In	NULL
fusion	NULL
transcripts	NULL
IT2	NULL
and	NULL
IT3	NULL
,	NULL
it	NULL
is	NULL
assumed	NULL
that	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
for	NULL
IT	NULL
1	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
including	NULL
the	NULL
normal	NULL
exon	NULL
1	NULL
of	NULL
GR6	NULL
.	NULL

This	NULL
has	NULL
not	NULL
been	NULL
determined	NULL
;	NULL
what	NULL
has	NULL
been	NULL
described	NULL
is	NULL
the	NULL
start	NULL
of	NULL
an	NULL
ORF	NULL
.	NULL

5°	NULL
RACE	NULL
from	NULL
EVI1	NULL
can	NULL
not	NULL
help	NULL
in	NULL
these	NULL
determinations	NULL
because	NULL
of	NULL
the	NULL
high	NULL
levels	NULL
of	NULL
activated	NULL
expression	NULL
of	NULL
the	NULL
(	NULL
apparently	NULL
)	NULL
normal	NULL
EVI1	NULL
transcript	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
in	NULL
the	NULL
UCSD-AML	NULL
1	NULL
cell	NULL
line	NULL
,	NULL
three	NULL
types	NULL
of	NULL
relevant	NULL
transcripts	NULL
are	NULL
seen	NULL
:	NULL
normal	NULL
EVII	NULL
transcripts	NULL
produced	NULL
by	NULL
breakpoint	NULL
activation	NULL
;	NULL
normal	NULL
GR6	NULL
transcripts	NULL
similarly	NULL
produced	NULL
by	NULL
breakpoint	NULL
activation	NULL
;	NULL
and	NULL
fusion	NULL
transcripts	NULL
between	NULL
GR6	NULL
and	NULL
EVI1	NULL
and	NULL
between	NULL
RBPH1	NULL
and	NULL
EVI	NULL
!	NULL

Discussion	NULL
We	NULL
have	NULL
identified	NULL
a	NULL
novel	NULL
gene	NULL
,	NULL
GR6	NULL
,	NULL
mapping	NULL
within	NULL
the	NULL
leukemia	NULL
breakpoint	NULL
region	NULL
of	NULL
3q21	NULL
,	NULL
a	NULL
band	NULL
frequently	NULL
associated	NULL
with	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
,	NULL
inv	NULL
(	NULL
3	NULL
)	NULL
,	NULL
and	NULL
del	NULL
(	NULL
3q21	NULL
)	NULL
in	NULL
AML	NULL
,	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
,	NULL
and	NULL
MDS	NULL
.	NULL

The	NULL
GR6	NULL
gene	NULL
is	NULL
composed	NULL
of	NULL
four	NULL
exons	NULL
,	NULL
with	NULL
an	NULL
ORF	NULL
of	NULL
150	NULL
amino	NULL
acids	NULL
located	NULL
within	NULL
exon	NULL
4	NULL
.	NULL

It	NULL
is	NULL
transcribed	NULL
telomere	NULL
to	NULL
3918	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1997	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

FUSION	NULL
TRANSCRIPTS	NULL
WITH	NULL
EVI	NULL
IN	NULL
LEUKEMIA	NULL
centromere	NULL
,	NULL
and	NULL
its	NULL
3	NULL
'	NULL
end	NULL
lies	NULL
1	NULL
kb	NULL
from	NULL
the	NULL
3q21	NULL
breakpoint	NULL
in	NULL
the	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
(	NULL
q21	NULL
;	NULL
q26	NULL
)	NULL
seen	NULL
in	NULL
the	NULL
leukemia-derived	NULL
cell	NULL
line	NULL
,	NULL
UCSD-AML1	NULL
.	NULL

The	NULL
putative	NULL
GR6	NULL
protein	NULL
shows	NULL
no	NULL
homology	NULL
with	NULL
any	NULL
proteins	NULL
in	NULL
the	NULL
databases	NULL
searched	NULL
with	NULL
Blast	NULL
.	NULL

Negative	NULL
Northern	NULL
results	NULL
with	NULL
adult	NULL
and	NULL
18-24-week	NULL
fetal	NULL
tissues	NULL
suggest	NULL
that	NULL
GR6	NULL
expression	NULL
is	NULL
,	NULL
at	NULL
best	NULL
,	NULL
low	NULL
in	NULL
normal	NULL
tissues	NULL
.	NULL

GR6	NULL
does	NULL
,	NULL
however	NULL
,	NULL
show	NULL
clear	NULL
expression	NULL
by	NULL
RT-PCR	NULL
in	NULL
whole	NULL
7-8-week	NULL
fetus	NULL
,	NULL
suggesting	NULL
potential	NULL
fetal	NULL
speci-ficity	NULL
.	NULL

Most	NULL
interestingly	NULL
,	NULL
it	NULL
is	NULL
negative	NULL
by	NULL
RT-PCR	NULL
in	NULL
fresh	NULL
adult	NULL
lymphocytes	NULL
but	NULL
clearly	NULL
expressed	NULL
in	NULL
the	NULL
UCSD-AML1	NULL
leukemic	NULL
cell	NULL
line	NULL
and	NULL
in	NULL
the	NULL
one	NULL
leukemic	NULL
sample	NULL
available	NULL
for	NULL
testing	NULL
.	NULL

The	NULL
locations	NULL
and	NULL
orientations	NULL
of	NULL
the	NULL
GR6	NULL
gene	NULL
,	NULL
the	NULL
P2	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
RBPH1	NULL
gene	NULL
in	NULL
3q21	NULL
,	NULL
relative	NULL
to	NULL
the	NULL
location	NULL
and	NULL
orientation	NULL
of	NULL
the	NULL
EV//	NULL
gene	NULL
in	NULL
3q26	NULL
in	NULL
the	NULL
UCSD-AMLA1	NULL
cell	NULL
line	NULL
,	NULL
suggested	NULL
the	NULL
possibility	NULL
of	NULL
fusion	NULL
transcripts	NULL
.	NULL

These	NULL
were	NULL
verified	NULL
between	NULL
GR6	NULL
and	NULL
EVIl	NULL
and	NULL
between	NULL
RBPH1	NULL
and	NULL
EVI1	NULL
.	NULL

In	NULL
each	NULL
of	NULL
the	NULL
fusions	NULL
,	NULL
additional	NULL
amino	NULL
acids	NULL
and	NULL
a	NULL
novel	NULL
transcription	NULL
start	NULL
site	NULL
are	NULL
spliced	NULL
into	NULL
exon	NULL
2	NULL
of	NULL
EVI1	NULL
.	NULL

The	NULL
additional	NULL
amino	NULL
acids	NULL
number	NULL
3	NULL
,	NULL
63	NULL
,	NULL
and	NULL
92	NULL
from	NULL
the	NULL
GR6	NULL
fusions	NULL
and	NULL
87	NULL
from	NULL
the	NULL
fusion	NULL
.	NULL

Exon	NULL
2	NULL
and	NULL
the	NULL
5¢	NULL
end	NULL
of	NULL
exon	NULL
3	NULL
of	NULL
EVI1	NULL
are	NULL
not	NULL
translated	NULL
in	NULL
the	NULL
EVII	NULL
protein	NULL
;	NULL
the	NULL
novel	NULL
start	NULL
sites	NULL
,	NULL
thus	NULL
,	NULL
also	NULL
add	NULL
63	NULL
amino	NULL
acids	NULL
of	NULL
EVIL	NULL
sequence	NULL
to	NULL
the	NULL
translations	NULL
.	NULL

Splicing	NULL
into	NULL
exon	NULL
2	NULL
of	NULL
the	NULL
EVI/Z	NULL
gene	NULL
is	NULL
a	NULL
normal	NULL
event	NULL
observed	NULL
in	NULL
pancreas	NULL
and	NULL
kidney	NULL
,	NULL
involving	NULL
the	NULL
3q26	NULL
upstream	NULL
MDSI	NULL
gene	NULL
(	NULL
6	NULL
)	NULL
.	NULL

It	NULL
is	NULL
believed	NULL
that	NULL
this	NULL
normal	NULL
intergenic	NULL
splicing	NULL
serves	NULL
to	NULL
alter	NULL
the	NULL
transacti-vating	NULL
properties	NULL
of	NULL
the	NULL
EVI1	NULL
transcription	NULL
factor	NULL
,	NULL
thus	NULL
altering	NULL
regulation	NULL
of	NULL
downstream	NULL
genes	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Abnormal	NULL
£EV//	NULL
exon	NULL
2	NULL
splicing	NULL
events	NULL
have	NULL
also	NULL
been	NULL
observed	NULL
in	NULL
leukemia	NULL
rearrangements	NULL
involving	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q26	NULL
;	NULL
g22	NULL
)	NULL
(	NULL
15	NULL
)	NULL
,	NULL
in	NULL
which	NULL
the	NULL
chromosome	NULL
21	NULL
breakpoint	NULL
occurs	NULL
in	NULL
intron	NULL
6	NULL
of	NULL
the	NULL
AMLI	NULL
gene	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
AML	NULL
!	NULL

gene	NULL
is	NULL
then	NULL
fused	NULL
either	NULL
with	NULL
exon	NULL
2	NULL
of	NULL
EVIl	NULL
directly	NULL
or	NULL
through	NULL
MDSI	NULL
or	NULL
the	NULL
gene	NULL
encoding	NULL
El	NULL
A-associated	NULL
protein	NULL
,	NULL
both	NULL
upstream	NULL
of	NULL
EVI1	NULL
.	NULL

Similar	NULL
aberrant	NULL
EVI	NULL
!	NULL

exon	NULL
2	NULL
splicing	NULL
has	NULL
also	NULL
been	NULL
observed	NULL
in	NULL
t	NULL
(	NULL
3	NULL
;	NULL
12	NULL
)	NULL
(	NULL
q26	NULL
;	NULL
p13	NULL
)	NULL
(	NULL
16	NULL
)	NULL
,	NULL
in	NULL
which	NULL
the	NULL
chromosome	NULL
12	NULL
breakpoint	NULL
occurs	NULL
within	NULL
the	NULL
ETV6	NULL
gene	NULL
.	NULL

In	NULL
a	NULL
fashion	NULL
analogous	NULL
to	NULL
the	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
,	NULL
the	NULL
first	NULL
two	NULL
exons	NULL
of	NULL
ETV6	NULL
are	NULL
spliced	NULL
to	NULL
EVI	NULL
]	NULL
or	NULL
MDSI-EVI1	NULL
.	NULL

Thus	NULL
,	NULL
there	NULL
are	NULL
several	NULL
examples	NULL
of	NULL
leukemia-associated	NULL
rearrangements	NULL
giving	NULL
rise	NULL
to	NULL
potential	NULL
translation	NULL
of	NULL
EVI	NULL
!	NULL

exons	NULL
2	NULL
and	NULL
3	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
may	NULL
be	NULL
a	NULL
critical	NULL
element	NULL
in	NULL
cases	NULL
with	NULL
EVI1	NULL
activation	NULL
.	NULL

A	NULL
novel	NULL
feature	NULL
of	NULL
the	NULL
3q21-EVI1	NULL
splicing	NULL
observed	NULL
here	NULL
is	NULL
that	NULL
the	NULL
3q21	NULL
breakpoint	NULL
occurs	NULL
downstream	NULL
of	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
each	NULL
of	NULL
the	NULL
genes	NULL
that	NULL
provide	NULL
the	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
fusion	NULL
products	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
not	NULL
the	NULL
more	NULL
commonly	NULL
observed	NULL
scenario	NULL
of	NULL
fusion	NULL
transcripts	NULL
produced	NULL
when	NULL
a	NULL
translocation	NULL
has	NULL
interrupted	NULL
a	NULL
gene	NULL
.	NULL

It	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
the	NULL
sequences	NULL
in	NULL
3q21	NULL
that	NULL
promote	NULL
these	NULL
intergenic	NULL
splicing	NULL
events	NULL
.	NULL

Unresolved	NULL
is	NULL
the	NULL
role	NULL
that	NULL
the	NULL
fusion	NULL
protein	NULL
products	NULL
may	NULL
play	NULL
in	NULL
leukemia	NULL
.	NULL

These	NULL
may	NULL
include	NULL
the	NULL
inappropriate	NULL
activation	NULL
of	NULL
EVI1	NULL
and	NULL
the	NULL
inappropriate	NULL
function	NULL
of	NULL
the	NULL
EVI1	NULL
protein	NULL
.	NULL

This	NULL
latter	NULL
,	NULL
at	NULL
least	NULL
,	NULL
is	NULL
strongly	NULL
suggested	NULL
by	NULL
the	NULL
analysis	NULL
of	NULL
normal	NULL
EVI1	NULL
and	NULL
MDS1/EVII	NULL
function	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Normal	NULL
EVI	NULL
!	NULL

protein	NULL
is	NULL
a	NULL
repressor	NULL
of	NULL
promoters	NULL
containing	NULL
the	NULL
AGATA	NULL
motif	NULL
,	NULL
whereas	NULL
normal	NULL
MDSI/EVII	NULL
is	NULL
a	NULL
strong	NULL
activator	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
activation	NULL
function	NULL
of	NULL
MDS1/EVII	NULL
protein	NULL
is	NULL
contained	NULL
within	NULL
the	NULL
segment	NULL
encoded	NULL
by	NULL
EV/Z	NULL
exons	NULL
2	NULL
and	NULL
3	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
GRG6-EVIl	NULL
and	NULL
RBPH1-EVI1	NULL
fusions	NULL
not	NULL
only	NULL
cause	NULL
expression	NULL
of	NULL
EVI	NULL
inappropriately	NULL
but	NULL
also	NULL
potentially	NULL
produce	NULL
proteins	NULL
with	NULL
EVI1	NULL
transcriptional	NULL
activator	NULL
properties	NULL
.	NULL

A	NULL
second	NULL
point	NULL
of	NULL
interest	NULL
involves	NULL
the	NULL
frequency	NULL
of	NULL
these	NULL
fusion	NULL
products	NULL
in	NULL
leukemias	NULL
with	NULL
rearrangements	NULL
affecting	NULL
3q21	NULL
and	NULL
3q26	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
shows	NULL
the	NULL
breakpoint	NULL
locations	NULL
relative	NULL
to	NULL
the	NULL
GR6	NULL
,	NULL
RBPHT	NULL
,	NULL
and	NULL
EVI	NULL
!	NULL

genes	NULL
for	NULL
a	NULL
number	NULL
of	NULL
cases	NULL
in	NULL
which	NULL
detailed	NULL
mapping	NULL
information	NULL
is	NULL
available	NULL
.	NULL

Several	NULL
features	NULL
are	NULL
noteworthy	NULL
.	NULL

First	NULL
,	NULL
for	NULL
all	NULL
cases	NULL
of	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
(	NULL
q21	NULL
;	NULL
q26	NULL
)	NULL
,	NULL
RBPHI-EVIl	NULL
fusion	NULL
can	NULL
occur	NULL
.	NULL

In	NULL
the	NULL
cases	NULL
of	NULL
t	NULL
(	NULL
1	NULL
;	NULL
3	NULL
)	NULL
,	NULL
RBPH1	NULL
is	NULL
also	NULL
correctly	NULL
positioned	NULL
and	NULL
oriented	NULL
for	NULL
producing	NULL
a	NULL
fusion	NULL
product	NULL
with	NULL
a	NULL
gene	NULL
from	NULL
chromosome	NULL
1	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
considering	NULL
all	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
for	NULL
the	NULL
GR6-EVIl	NULL
fusion	NULL
to	NULL
occur	NULL
only	NULL
in	NULL
the	NULL
UCSD-AML1	NULL
example	NULL
,	NULL
and	NULL
GR6	NULL
is	NULL
also	NULL
oriented	NULL
incorrectly	NULL
in	NULL
both	NULL
t	NULL
(	NULL
1	NULL
;	NULL
3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
may	NULL
be	NULL
postulated	NULL
the	NULL
fusion	NULL
of	NULL
RBPHI1	NULL
is	NULL
the	NULL
critical	NULL
event	NULL
in	NULL
leukemias	NULL
with	NULL
t	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
.	NULL

The	NULL
production	NULL
of	NULL
additional	NULL
fusion	NULL
products	NULL
may	NULL
affect	NULL
some	NULL
aspects	NULL
of	NULL
the	NULL
leukemia	NULL
phenotype	NULL
.	NULL

Even	NULL
fusions	NULL
,	NULL
however	NULL
,	NULL
are	NULL
unlikely	NULL
to	NULL
be	NULL
the	NULL
entire	NULL
story	NULL
for	NULL
3q21	NULL
rearrangements	NULL
in	NULL
leukemia	NULL
.	NULL

In	NULL
cases	NULL
of	NULL
inv	NULL
(	NULL
3	NULL
)	NULL
,	NULL
RBPHI1	NULL
is	NULL
transcribed	NULL
in	NULL
the	NULL
opposite	NULL
orientation	NULL
relative	NULL
to	NULL
the	NULL
breakpoints	NULL
and	NULL
EVI	NULL
!	NULL

transcription	NULL
.	NULL

In	NULL
these	NULL
cases	NULL
,	NULL
the	NULL
fusion	NULL
partners	NULL
may	NULL
still	NULL
be	NULL
one	NULL
of	NULL
several	NULL
novel	NULL
transcripts	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
or	NULL
yet	NULL
to	NULL
be	NULL
discovered	NULL
in	NULL
3q21	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
R.	NULL
Taetle	NULL
of	NULL
the	NULL
Arizona	NULL
Cancer	NULL
Center	NULL
,	NULL
Tucson	NULL
,	NULL
for	NULL
his	NULL
generous	NULL
contribution	NULL
of	NULL
the	NULL
UCSD-AMLA1	NULL
cell	NULL
line	NULL
.	NULL

References	NULL
.	NULL

Mitelman	NULL
,	NULL
F.	NULL
,	NULL
Mertens	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Johansson	NULL
,	NULL
B	NULL
.	NULL

A	NULL
breakpoint	NULL
map	NULL
of	NULL
recurrent	NULL
chromosomal	NULL
rearrangements	NULL
in	NULL
human	NULL
neoplasia	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
75	NULL
;	NULL
417-440	NULL
,	NULL
1997.	NULL
.	NULL

Morishita	NULL
,	NULL
K.	NULL
,	NULL
Parganas	NULL
,	NULL
E.	NULL
,	NULL
Willman	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Whittaker	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Drabkin	NULL
,	NULL
H.	NULL
,	NULL
Oval	NULL
,	NULL
J.	NULL
,	NULL
Tactle	NULL
,	NULL
R.	NULL
,	NULL
Valentine	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
Activation	NULL
of	NULL
EVI1	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
acute	NULL
myelogenous	NULL
leukemias	NULL
by	NULL
translocations	NULL
spanning	NULL
300-400	NULL
kilobases	NULL
on	NULL
chromosome	NULL
band	NULL
3q26	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
:	NULL
3937-3941	NULL
,	NULL
1992.	NULL
.	NULL

Fichelson	NULL
,	NULL
S.	NULL
,	NULL
Dreyfus	NULL
,	NULL
F.	NULL
,	NULL
Berger	NULL
,	NULL
R.	NULL
,	NULL
Melle	NULL
,	NULL
J.	NULL
,	NULL
Bastard	NULL
,	NULL
C.	NULL
,	NULL
Miclea	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Gisselbrecht	NULL
,	NULL
S.	NULL
EVI1	NULL
expression	NULL
in	NULL
leukemia	NULL
patients	NULL
with	NULL
rearrangements	NULL
of	NULL
the	NULL
3q25-q28	NULL
chromosome	NULL
region	NULL
.	NULL

Leukemia	NULL
(	NULL
Baltimore	NULL
)	NULL
,	NULL
6	NULL
:	NULL
1-8	NULL
,	NULL
1995	NULL
.	NULL

4	NULL
.	NULL

Levy	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
Parganas	NULL
,	NULL
E.	NULL
,	NULL
Morishita	NULL
,	NULL
K.	NULL
,	NULL
Fichelson	NULL
,	NULL
S.	NULL
,	NULL
James	NULL
,	NULL
L.	NULL
,	NULL
Oscier	NULL
,	NULL
D.	NULL
,	NULL
Gisselbrecht	NULL
,	NULL
S.	NULL
,	NULL
Thie	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
Buckle	NULL
,	NULL
V.	NULL
J.	NULL
DNA	NULL
rearrangements	NULL
proximal	NULL
to	NULL
the	NULL
EVI1	NULL
locus	NULL
associated	NULL
with	NULL
the	NULL
3q21q26	NULL
syndrome	NULL
.	NULL

Blood	NULL
,	NULL
83	NULL
:	NULL
1348-1354	NULL
,	NULL
1994	NULL
.	NULL

5	NULL
.	NULL

Russell	NULL
,	NULL
M.	NULL
,	NULL
List	NULL
,	NULL
A.	NULL
,	NULL
Greenberg	NULL
,	NULL
P.	NULL
,	NULL
Woodward	NULL
,	NULL
S.	NULL
,	NULL
Glinsmann	NULL
,	NULL
B.	NULL
,	NULL
Parganas	NULL
,	NULL
E.	NULL
,	NULL
Thle	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Tactle	NULL
,	NULL
R.	NULL
Expression	NULL
of	NULL
EVI1	NULL
in	NULL
myelodysplastic	NULL
syndromes	NULL
and	NULL
other	NULL
hematologic	NULL
malignancies	NULL
without	NULL
3q26	NULL
translocations	NULL
.	NULL

Blood	NULL
,	NULL
84	NULL
:	NULL
1243-1248	NULL
,	NULL
1994	NULL
.	NULL

6	NULL
.	NULL

Fears	NULL
,	NULL
S.	NULL
,	NULL
Mathiel	NULL
,	NULL
C.	NULL
,	NULL
Zeleznik-Le	NULL
,	NULL
N.	NULL
,	NULL
Huang	NULL
,	NULL
S.	NULL
,	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Nucifora	NULL
,	NULL
G.	NULL
Intergenic	NULL
splicing	NULL
of	NULL
MDSI	NULL
and	NULL
occurs	NULL
in	NULL
normal	NULL
tissues	NULL
as	NULL
well	NULL
as	NULL
in	NULL
myeloid	NULL
leukemia	NULL
and	NULL
produces	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
PR	NULL
domain	NULL
family	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
93	NULL
:	NULL
1642-1647	NULL
,	NULL
1996	NULL
.	NULL

7	NULL
.	NULL

Suzukawa	NULL
,	NULL
K.	NULL
,	NULL
Parganas	NULL
,	NULL
E.	NULL
,	NULL
Gajjar	NULL
,	NULL
A.	NULL
,	NULL
Abe	NULL
,	NULL
T.	NULL
,	NULL
Takahashi	NULL
,	NULL
S.	NULL
,	NULL
Tani	NULL
,	NULL
K.	NULL
,	NULL
Asou	NULL
,	NULL
H.	NULL
,	NULL
Kamada	NULL
,	NULL
N.	NULL
,	NULL
Yokoto	NULL
,	NULL
J.	NULL
,	NULL
Morishita	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Thie	NULL
,	NULL
J	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
breakpoint	NULL
cluster	NULL
region	NULL
3	NULL
'	NULL
of	NULL
the	NULL
Ribophorin	NULL
I	NULL
gene	NULL
at	NULL
3q21	NULL
associated	NULL
with	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
EVI1	NULL
gene	NULL
in	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
with	NULL
inv	NULL
(	NULL
3	NULL
)	NULL
(	NULL
q21q26	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
84	NULL
:	NULL
2681-2688	NULL
,	NULL
1994.	NULL
.	NULL

Pekarsky	NULL
,	NULL
Y.	NULL
,	NULL
Zabarovsky	NULL
,	NULL
E.	NULL
,	NULL
Kashuba	NULL
,	NULL
V.	NULL
,	NULL
Drabkin	NULL
,	NULL
H.	NULL
,	NULL
Sandberg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Morgan	NULL
,	NULL
R.	NULL
,	NULL
Rynditch	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Gardiner	NULL
,	NULL
K.	NULL
Cloning	NULL
of	NULL
breakpoints	NULL
in	NULL
3q21	NULL
associated	NULL
with	NULL
hematologic	NULL
malignancy	NULL
.	NULL

Cancer	NULL
Genet	NULL
.	NULL

Cytogenet	NULL
.	NULL

,	NULL
80	NULL
:	NULL
1-8	NULL
,	NULL
1995	NULL
.	NULL

9	NULL
.	NULL

Rynditch	NULL
,	NULL
A.	NULL
,	NULL
Pekarsky	NULL
,	NULL
Y.	NULL
,	NULL
Schnittger	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Gardiner	NULL
,	NULL
K.	NULL
Leukemia	NULL
breakpoint	NULL
region	NULL
in	NULL
3q21	NULL
is	NULL
gene	NULL
rich	NULL
.	NULL

Gene	NULL
,	NULL
793	NULL
;	NULL
49-57	NULL
,	NULL
1997	NULL
.	NULL

10	NULL
.	NULL

Oval	NULL
,	NULL
J.	NULL
,	NULL
Jones	NULL
,	NULL
O.	NULL
W.	NULL
,	NULL
Montoya	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Taetle	NULL
,	NULL
R.	NULL
Characterization	NULL
of	NULL
a	NULL
factor-dependent	NULL
acute	NULL
leukemia	NULL
cell	NULL
line	NULL
with	NULL
translocation	NULL
(	NULL
3	NULL
;	NULL
3	NULL
)	NULL
(	NULL
q21	NULL
;	NULL
q26	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
76	NULL
:	NULL
1369-1373	NULL
,	NULL
1990	NULL
.	NULL

11	NULL
.	NULL

Uberbacher	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
and	NULL
Mural	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

Locating	NULL
protein-coding	NULL
regions	NULL
in	NULL
human	NULL
DNA	NULL
sequences	NULL
by	NULL
a	NULL
multiple	NULL
sensor-neural	NULL
network	NULL
approach	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
:	NULL
11261-11265	NULL
,	NULL
1991	NULL
.	NULL

12	NULL
.	NULL

Chomczynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
Single	NULL
step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
762	NULL
:	NULL
156-159	NULL
,	NULL
1987	NULL
.	NULL

13	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T	NULL
.	NULL

(	NULL
eds	NULL
.	NULL
)	NULL

.	NULL

Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
Ed	NULL
.	NULL

2	NULL
,	NULL
pp	NULL
.	NULL

5.3-6.48	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
:	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Labora-tory	NULL
,	NULL
1989	NULL
.	NULL

14	NULL
.	NULL

Kawasaki	NULL
,	NULL
E.	NULL
S.	NULL
Amplification	NULL
of	NULL
RNA	NULL
.	NULL

/n	NULL
:	NULL
M.	NULL
A.	NULL
Innis	NULL
,	NULL
D.	NULL
H.	NULL
Gelfand	NULL
,	NULL
J.	NULL
J.	NULL
Sninsky	NULL
,	NULL
and	NULL
T.	NULL
J	NULL
.	NULL

White	NULL
(	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
PCR	NULL
Protocols	NULL
:	NULL
A	NULL
Guide	NULL
to	NULL
Methods	NULL
and	NULL
Applications	NULL
,	NULL
pp	NULL
.	NULL

21-27	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Academic	NULL
Press	NULL
,	NULL
1990	NULL
.	NULL

15	NULL
.	NULL

Nucifora	NULL
,	NULL
G.	NULL
,	NULL
Begy	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Kobayashi	NULL
,	NULL
H.	NULL
,	NULL
Roulston	NULL
,	NULL
D.	NULL
,	NULL
Claxton	NULL
,	NULL
D.	NULL
,	NULL
Pedersen-Bjergaard	NULL
,	NULL
J.	NULL
,	NULL
Parganas	NULL
,	NULL
E.	NULL
,	NULL
Ihie	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
Consistent	NULL
intragenic	NULL
splicing	NULL
and	NULL
production	NULL
of	NULL
multiple	NULL
transcripts	NULL
between	NULL
AML	NULL
1	NULL
at	NULL
21q22	NULL
and	NULL
unrelated	NULL
genes	NULL
at	NULL
3q26	NULL
in	NULL
(	NULL
3	NULL
:	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q26	NULL
;	NULL
q22	NULL
)	NULL
translocations	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
97	NULL
;	NULL
4004-4008	NULL
,	NULL
1994	NULL
.	NULL

16	NULL
.	NULL

Peeters	NULL
,	NULL
P.	NULL
,	NULL
Wlodarska	NULL
,	NULL
L.	NULL
,	NULL
Baens	NULL
,	NULL
M.	NULL
,	NULL
Criel	NULL
,	NULL
A.	NULL
,	NULL
Selleslag	NULL
,	NULL
D.	NULL
,	NULL
Hagemeyer	NULL
,	NULL
A.	NULL
,	NULL
Van	NULL
den	NULL
Berghe	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Marynen	NULL
,	NULL
P.	NULL
Fusion	NULL
of	NULL
ETV6	NULL
as	NULL
a	NULL
result	NULL
of	NULL
t	NULL
(	NULL
3	NULL
;	NULL
12	NULL
)	NULL
(	NULL
q16	NULL
;	NULL
p13	NULL
)	NULL
in	NULL
myeloproliferative	NULL
disorders	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
57	NULL
:	NULL
564-569	NULL
,	NULL
1997	NULL
.	NULL

17	NULL
.	NULL

Morishita	NULL
,	NULL
K.	NULL
,	NULL
Parganas	NULL
,	NULL
E.	NULL
,	NULL
Douglass	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
and	NULL
Thle	NULL
,	NULL
I.	NULL
N.	NULL
Unique	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
EVII	NULL
gene	NULL
in	NULL
an	NULL
endometrial	NULL
carcinoma	NULL
cell	NULL
line	NULL
:	NULL
sequence	NULL
of	NULL
the	NULL
cDNA	NULL
and	NULL
structure	NULL
of	NULL
alternatively	NULL
spliced	NULL
transcripts	NULL
.	NULL

Oncogene	NULL
,	NULL
5	NULL
:	NULL
963-971	NULL
,	NULL
1990	NULL
,	NULL
18	NULL
.	NULL

Soderholm	NULL
,	NULL
I.	NULL
,	NULL
Kobayashi	NULL
,	NULL
H.	NULL
,	NULL
Mathieu	NULL
,	NULL
C.	NULL
,	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Nucifora	NULL
,	NULL
G.	NULL
The	NULL
leukemia-associated	NULL
gene	NULL
MDS//EVZ	NULL
!	NULL

is	NULL
a	NULL
new	NULL
type	NULL
of	NULL
GATA-binding	NULL
transactivator	NULL
.	NULL

Leukemia	NULL
(	NULL
Baltimore	NULL
)	NULL
,	NULL
77	NULL
:	NULL
352-358	NULL
,	NULL
1997	NULL
.	NULL

19	NULL
.	NULL

Pekarsky	NULL
,	NULL
Y.	NULL
Cloning	NULL
,	NULL
characterization	NULL
,	NULL
and	NULL
transcriptional	NULL
mapping	NULL
of	NULL
the	NULL
3q21	NULL
leukemia	NULL
breakpoint	NULL
region	NULL
.	NULL

(	NULL
Thesis	NULL
)	NULL
,	NULL
Denver	NULL
,	NULL
CO	NULL
:	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Sciences	NULL
Center	NULL
,	NULL
1997	NULL
.	NULL

20	NULL
.	NULL

Behal	NULL
,	NULL
A.	NULL
,	NULL
Prakash	NULL
,	NULL
K.	NULL
,	NULL
D'Estachio	NULL
,	NULL
P.	NULL
,	NULL
Adesnik	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Kreibich	NULL
,	NULL
G.	NULL
Structure	NULL
and	NULL
chromosomal	NULL
location	NULL
of	NULL
the	NULL
rat	NULL
Ribophorin	NULL
I	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
265	NULL
:	NULL
8252-8258	NULL
,	NULL
1990.	NULL
bo	NULL
t	NULL
oo	NULL
3919	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1997	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

AAGR	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
Cancer	NULL
Research	NULL
The	NULL
Journal	NULL
of	NULL
Cancer	NULL
Research	NULL
(	NULL
1916-1930	NULL
)	NULL
|	NULL
The	NULL
American	NULL
Journal	NULL
of	NULL
Cancer	NULL
(	NULL
1931-1940	NULL
)	NULL
Activation	NULL
of	NULL
a	NULL
Novel	NULL
Gene	NULL
in	NULL
3q21	NULL
and	NULL
Identification	NULL
of	NULL
Intergenic	NULL
Fusion	NULL
Transcripts	NULL
with	NULL
Ecotropic	NULL
Viral	NULL
Insertion	NULL
Site	NULL
I	NULL
in	NULL
Leukemia	NULL
Yuri	NULL
Pekarsky	NULL
,	NULL
Alla	NULL
Rynditch	NULL
,	NULL
Rotraud	NULL
Wieser	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Cancer	NULL
Res	NULL
1997	NULL
;	NULL
57:3914-3919	NULL
.	NULL

Updated	NULL
version	NULL
_	NULL
Access	NULL
the	NULL
most	NULL
recent	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/57/18/3914	NULL
E-mail	NULL
alerts	NULL
_	NULL
Sign	NULL
up	NULL
to	NULL
receive	NULL
free	NULL
email-alerts	NULL
related	NULL
to	NULL
this	NULL
article	NULL
or	NULL
journal	NULL
.	NULL

Reprints	NULL
and	NULL
_	NULL
To	NULL
order	NULL
reprints	NULL
of	NULL
this	NULL
article	NULL
or	NULL
to	NULL
subscribe	NULL
to	NULL
the	NULL
journal	NULL
,	NULL
contact	NULL
the	NULL
AACR	NULL
Publications	NULL
Subscriptions	NULL
_	NULL
Department	NULL
at	NULL
pubs	NULL
@	NULL
aacr.org	NULL
.	NULL

Permissions	NULL
_	NULL
To	NULL
request	NULL
permission	NULL
to	NULL
re-use	NULL
all	NULL
or	NULL
part	NULL
of	NULL
this	NULL
article	NULL
,	NULL
use	NULL
this	NULL
link	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/57/18/3914	NULL
.	NULL

Click	NULL
on	NULL
``	NULL
Request	NULL
Permissions	NULL
``	NULL
which	NULL
will	NULL
take	NULL
you	NULL
to	NULL
the	NULL
Copyright	NULL
Clearance	NULL
Center	NULL
's	NULL
(	NULL
CCC	NULL
)	NULL
Rightslink	NULL
site	NULL
.	NULL

Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1997	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

